Other diseases of oesophagus

K11_OTHDISOES

esophageal disease: A non-neoplastic or neoplastic disorder that affects the esophagus. Representative examples of non-neoplastic disorders include esophagitis and esophageal ulcer. Representative examples of neoplastic disorders include carcinomas, lymphomas, and melanomas.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K22.4, K22.5, K22.6, K22.7, K22.8, K22.9 Hospital discharge: ICD-9 — 530[5-9] Hospital discharge: ICD-8 — 5302\|5309 Hospital discharge: excluded ICD-10 — K22.7 Cause of death: ICD-10 — K22.4, K22.5, K22.6, K22.7, K22.8, K22.9 Cause of death: ICD-9 — 530[5-9] Cause of death: ICD-8 — 5302\|5309 2 out of 7 registries used, show all original rules.	4022
4. Check minimum number of events None	4022
5. Include endpoints None	4022
6. Filter based on genotype QC (FinnGen only)	4022

Control definitions (FinnGen only)

Control exclude: K11_OESSTODUO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	K11_OTHDISOES
CONTROL_EXCLUDE	K11_OESSTODUO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K22[4-9]
HD_ICD_9	530[5-9]
HD_ICD_8	5302\|5309
HD_ICD_10_EXCL	K227
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K22[4-9]
COD_ICD_9	530[5-9]
COD_ICD_8	5302\|5309
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other diseases of oesophagus based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	36883	15648	20710
Only index persons	26347	11658	14689
Unadjusted period prevalence (%)
Whole population	0.52	0.45	0.58
Only index persons	0.50	0.43	0.56
Median age at first event (years)
Whole population	58.42	61.45	56.04
Only index persons	55.31	57.65	53.45

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4022	1805	2217
Unadjusted period prevalence (%)	0.81	0.62	0.98
Median age at first event (years)	56.25	55.13	57.16

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3617: Matched controls
36160

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

+∞

323.0

725

K22.5

ICD-10 Finland

Diverticulum of oesophagus, acquired

+∞

323.0

440

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

15.9

323.0

2267

3444

5308A

ICD-9 Finland

Diseases of oesophagus, Other specified disorders of oesophagus[HERNIA HIATUS OESOPHAGI (""""SLIDING HERNIA"""")]

+∞

323.0

475

K22.9

ICD-10 Finland

Disease of oesophagus, unspecified

385.4

323.0

445

R13

ICD-10 Finland

Dysphagia

11.4

323.0

780

853

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

25.6

323.0

658

311

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

3051.8

323.0

768

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

39.7

323.0

767

243

K22.8

ICD-10 Finland

Other specified diseases of oesophagus

1804.5

323.0

319

K92.0

ICD-10 Finland

Haematemesis

29.4

321.0

441

170

A02BC05

ATC

esomeprazole; systemic

3.8

299.2

1893

8086

A02BC02

ATC

pantoprazole; systemic

3.6

263.5

2699

16205

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

9.8

257.6

555

657

6241

FHL

Fund application (Nissen)

660.0

252.5

247

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

99.5

251.3

276

A02BC01

ATC

omeprazole; systemic

3.6

237.5

1443

5653

53094

ICD-8 Finland

Diseases of oesophagus, Oesophagitis

+∞

237.1

225

K22.1

ICD-10 Finland

Ulcer of oesophagus

460.7

220.2

218

A02BC03

ATC

lansoprazole; oral

3.4

217.1

1410

5726

A02BA02

ATC

ranitidine; systemic

3.6

191.3

1064

3756

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

47.0

190.3

234

K22.2

ICD-10 Finland

Oesophageal obstruction

278.8

182.5

185

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.9

174.9

1477

6939

A03FA02

ATC

cisapride; oral, rectal

5.3

159.7

530

1124

UJD02

NOMESCO Finland

Gastroscopy

9.7

156.3

334

377

5307A

ICD-9 Finland

Diseases of oesophagus, Gastrooesophageal laceration-haemorrhage syndrome

+∞

153.2

146

UJF32

NOMESCO Finland

Coloscopy

2.9

149.6

1168

5102

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

25.8

143.3

203

K22.0

ICD-10 Finland

Achalasia of cardia

+∞

137.3

131

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

88.1

136.3

152

5301A

ICD-9 Finland

Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]

+∞

124.7

119

K30

ICD-10 Finland

Functional dyspepsia

5.3

120.8

399

829

K29.3

ICD-10 Finland

Chronic superficial gastritis

66.2

115.7

134

K29.7

ICD-10 Finland

Gastritis, unspecified

23.8

111.9

162

R10.1

ICD-10 Finland

Pain localized to upper abdomen

3.1

105.6

663

2423

JCA98

NOMESCO Finland

Other local endoscopic operation on oesophagus

276.3

105.4

107

UJC02

NOMESCO Finland

Rigid oesophagoscopy

23.9

101.8

147

K20

ICD-10 Finland

Oesophagitis

28.1

100.1

138

N02AX02

ATC

tramadol; systemic, rectal

2.1

96.3

1652

10263

R07.4

ICD-10 Finland

Chest pain, unspecified

2.3

95.3

1107

5751

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.7

94.7

780

3369

K92.1

ICD-10 Finland

Melaena

5.1

93.4

313

655

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

14.6

93.0

160

114

K22.7

ICD-10 Finland

Barrett oesophagus

87.5

91.5

102

Z01.8

ICD-10 Finland

Other specified special examinations

2.5

90.0

874

4121

A02BC04

ATC

rabeprazole; oral

4.2

89.9

373

969

UJC12

NOMESCO Finland

Flexible oesophagoscopy

29.2

87.4

119

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

18.5

84.1

132

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

84.1

1675

10854

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

130.2

83.3

R06.0

ICD-10 Finland

Dyspnoea

2.2

83.0

1020

5374

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

89.1

78.3

A06AC01

ATC

ispaghula (psylla seeds); oral

2.2

77.3

946

4945

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.0

77.3

337

912

N06AX11

ATC

mirtazapine; oral

2.1

75.2

1154

6649

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

34.7

75.2

R11

ICD-10 Finland

Nausea and vomiting

3.5

72.7

376

1171

N03AX16

ATC

pregabalin; oral

2.2

71.7

904

4762

N05CF01

ATC

zopiclone; oral

2.0

71.4

1276

7778

A02BA04

ATC

nizatidine; systemic

3.3

71.2

393

1286

P01AB01

ATC

metronidazole; oral, rectal

2.0

70.7

1336

8314

JCA60

NOMESCO Finland

Transcervical excision of diverticulum of oesophagus

701.2

70.3

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

690.8

69.2

XJC00

NOMESCO Finland

Oesophageal manometry

109.3

69.1

WX408

NOMESCO Finland

General anesthesy, balanced

2.1

67.4

1036

5917

K29.4

ICD-10 Finland

Chronic atrophic gastritis

30.7

67.1

R03AC02

ATC

salbutamol; inhalant

1.8

65.3

1759

12304

A03FA01

ATC

metoclopramide; systemic, rectal

2.2

63.9

787

4072

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

63.9

833

4423

H02AB06

ATC

prednisolone; systemic

1.8

62.6

1673

11615

J02AC01

ATC

fluconazole; systemic

1.9

62.4

1216

7562

J45.9

ICD-10 Finland

Asthma, unspecified

2.3

60.9

682

3370

R51.80

ICD-10 Finland

Headache

2.6

60.4

502

2127

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

59.7

619

2945

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.3

59.4

665

3279

UJF30

NOMESCO Finland

Ileoscopy through colon

3.1

59.1

361

1261

53098

ICD-8 Finland

Diseases of oesophagus, Alii definiti

+∞

58.5

WX002

NOMESCO Finland

Sedation and analgesia

2.1

57.0

768

4109

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.6

56.9

445

1818

5308X

ICD-9 Finland

Diseases of oesophagus, Other specified disorders of oesophagus[MUU RUOKATORVISAIRAUS]

+∞

56.4

N03AX12

ATC

gabapentin; oral

2.3

55.6

588

2816

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.4

55.4

552

2566

R53

ICD-10 Finland

Malaise and fatigue

2.1

54.8

773

4203

N05BA04

ATC

oxazepam; oral

2.0

54.8

893

5146

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.4

53.6

508

2300

53099

ICD-8 Finland

Diseases of oesophagus, Other

+∞

53.2

JDA32

NOMESCO Finland

Endoscopic injection in stomach or pylorus

186.0

53.1

D64.9

ICD-10 Finland

Anaemia, unspecified

2.5

52.4

440

1867

J01DB01

ATC

cefalexin; oral

1.8

52.0

2762

23135

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

51.7

1002

6132

N05CD07

ATC

temazepam; oral

2.2

51.2

565

2749

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.1

51.0

300

1019

J01MA02

ATC

ciprofloxacin; systemic

1.7

50.8

1418

9763

N06AX21

ATC

duloxetine; oral

2.7

49.8

373

1478

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

49.7

725

3980

J01MA12

ATC

levofloxacin; systemic

2.0

49.1

723

3979

N06AA09

ATC

amitriptyline; systemic

2.6

49.1

392

1612

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.5

49.1

438

1914

R12

ICD-10 Finland

Heartburn

3.4

48.3

254

795

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.2

48.1

542

2657

C03CA01

ATC

furosemide; systemic

1.8

48.0

1209

8024

K29.8

ICD-10 Finland

Duodenitis

168.8

47.9

N05BA01

ATC

diazepam; systemic, rectal

2.3

47.9

512

2448

XJC10

NOMESCO Finland

Oesophageal pH monitoring

126.6

46.9

T18.1

ICD-10 Finland

Foreign body in oesophagus

11.9

46.6

C07AB07

ATC

bisoprolol; oral

1.7

46.6

1741

12940

A06AD11

ATC

lactulose; oral

2.1

46.4

621

3282

M79.6

ICD-10 Finland

Pain in limb

1.7

45.8

1160

7688

AA1AD

NOMESCO Finland

CT of head and brain

1.8

45.5

917

5643

TJX90

NOMESCO Finland

Other minor procedure in gastroenterological surgery

46.5

45.1

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

232.7

45.0

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

44.9

964

6053

C08CA05

ATC

nifedipine; systemic

2.7

44.6

333

1316

A07AA02

ATC

nystatin; oral

3.0

44.4

269

928

K29.1

ICD-10 Finland

Other acute gastritis

36.1

44.4

N06AB04

ATC

citalopram; systemic

1.9

44.2

736

4226

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

43.4

1098

7244

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

4.1

42.6

175

446

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

42.4

320

1272

R07.3

ICD-10 Finland

Other chest pain

2.5

42.1

358

1520

R03BA05

ATC

fluticasone; inhalant

2.0

42.0

612

3333

JCA96

NOMESCO Finland

Other local operation on oesophagus

+∞

41.7

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

41.4

1488

10814

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

67.9

41.1

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

41.1

646

3620

A02BA03

ATC

famotidine; systemic

3.6

40.7

196

572

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.4

40.5

382

1711

J01DA01

ATC

[U] cefalexin; systemic

1.6

40.5

2110

16851

G44.2

ICD-10 Finland

Tension-type headache

2.3

40.3

415

1942

JCA42

NOMESCO Finland

Other endoscopic procedure for hemostasis

401.7

40.2

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

76.0

39.9

JCA12

NOMESCO Finland

Division of oesophageal diverticulum during oesophagoscopy

391.4

39.1

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

202.0

38.9

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

38.8

1580

11803

M54.5

ICD-10 Finland

Low back pain

1.7

38.8

1002

6609

1310

FHL

Esophagogastroscopy

21.8

38.3

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.1

38.1

219

730

R42

ICD-10 Finland

Dizziness and giddiness

1.8

38.1

778

4764

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

38.0

601

3365

D01

ICPC

Abdominal pain/cramps general

2.5

38.0

330

1416

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

196.9

37.9

J01AA02

ATC

doxycycline; systemic

1.6

37.8

2605

22141

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

37.7

1115

7630

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

6.1

37.6

105

176

55130

ICD-8 Finland

Other hernia of abdominal cavity without mention of obstruction, Diaphragmatic

22.8

37.4

XF402

NOMESCO Finland

ECG with work load test

2.2

37.0

411

1987

N02BE01

ATC

paracetamol; systemic, rectal

1.7

36.8

2911

25571

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

4.8

36.7

125

265

N06AB03

ATC

fluoxetine; oral

2.2

36.7

418

2044

A02BX02

ATC

sucralfate; oral

3.3

36.5

194

611

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

+∞

36.5

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

3.2

36.1

199

644

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

35.6

622

3600

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

35.5

661

3912

53096

ICD-8 Finland

Diseases of oesophagus, Diverticulum

+∞

35.5

53091

ICD-8 Finland

Diseases of oesophagus, Strictura

+∞

35.5

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

35.4

624

3621

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

6.9

34.5

131

R03BB04

ATC

tiotropium bromide; inhalant

2.1

34.5

409

2032

J37.0

ICD-10 Finland

Chronic laryngitis

4.3

34.2

132

318

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

34.2

1050

7222

J01CA04

ATC

amoxicillin; systemic

1.6

33.7

2589

22197

K29.6

ICD-10 Finland

Other gastritis

36.2

33.7

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.5

33.6

274

1134

K59.0

ICD-10 Finland

Constipation

2.8

33.6

232

873

R06AE07

ATC

cetirizine; oral

1.6

33.5

1289

9379

F10.20

ICD-10 Finland

Alcohol dependence currently independent

5.7

33.4

179

JCE21

NOMESCO Finland

Laparoscopic cardiomyotomy

+∞

33.4

N07BB01

ATC

disulfiram; oral

3.4

33.3

169

514

A01AB09

ATC

miconazole; local oral

2.3

33.3

330

1510

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

14.1

33.3

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

33.3

1161

8240

R03DC03

ATC

montelukast; oral

2.0

33.3

478

2571

Q39.6

ICD-10 Finland

Diverticulum of oesophagus

63.9

33.0

R02

ICPC

Shortness of breath/dyspnoea

2.1

32.5

427

2213

N05AH04

ATC

quetiapine; oral

1.9

32.5

506

2804

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

7.3

32.4

110

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

32.4

606

3580

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.9

32.3

139

370

N06AX16

ATC

venlafaxine; oral

2.1

32.2

393

1977

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.2

32.0

346

1649

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

32.0

841

5520

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.0

31.8

193

667

F10.25

ICD-10 Finland

Alcohol dependence continuous use

6.2

31.7

143

M03BX02

ATC

tizanidine; oral

1.5

31.6

1819

14477

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.7

31.6

145

408

A03CA02

ATC

clidinium and psycholeptics; oral

2.6

31.6

242

968

K22.3

ICD-10 Finland

Perforation of oesophagus

+∞

31.3

SPAT1263

SPAT

Sampling

1.5

31.3

1377

10304

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.5

31.2

151

443

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.9

31.2

197

700

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.4

31.1

275

1187

J01FA09

ATC

clarithromycin; systemic

1.6

31.1

933

6344

C05AA08

ATC

fluocortolone; rectal, topical

1.9

31.0

479

2641

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

30.9

335

1595

UKC02

NOMESCO Finland

Cystoscopy

1.8

30.9

632

3841

J01FA06

ATC

roxithromycin; oral

1.5

30.8

1283

9468

K25.4

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with haemorrhage

85.8

30.8

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

30.7

839

5558

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

110.9

30.7

M25.5

ICD-10 Finland

Pain in joint

1.7

30.7

830

5482

R01AD09

ATC

mometasone; nasal

1.5

30.6

1277

9424

5355X

ICD-9 Finland

Gastritis and duodenitis, Unspecified gastritis and gastroduodenitis

+∞

30.2

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

5.9

30.1

149

J01FA10

ATC

azithromycin; systemic

1.5

30.1

1662

13053

JN3AD

NOMESCO Finland

Abdominal CT examination

2.4

30.1

271

1181

S06.0

ICD-10 Finland

Concussion

2.1

30.0

352

1737

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

29.8

481

2694

D21

ICPC

Swallowing problem

5.6

29.8

159

WX110

NOMESCO Finland

Local anesthesy

1.5

29.7

2116

17535

R52.2

ICD-10 Finland

Other chronic pain

3.8

29.4

130

355

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

29.3

752

4883

N02AA05

ATC

oxycodone; systemic

1.8

29.0

552

3274

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

4.0

28.9

118

300

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

28.8

350

1753

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

28.5

556

3322

N06AA12

ATC

doxepin; systemic

2.6

28.4

211

826

J45.1

ICD-10 Finland

Nonallergic asthma

2.5

28.4

237

991

ZXC10

NOMESCO Finland

Use of laser

4.2

28.3

111

272

R01AD08

ATC

fluticasone; nasal

1.6

28.3

829

5576

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

+∞

28.1

R03BA02

ATC

budesonide; inhalant

1.8

27.9

546

3259

UJF92

NOMESCO Finland

Capsular endoscopy

5.6

27.9

148

SPAT1254

SPAT

Administration of medicine

1.8

27.8

528

3124

D02

ICPC

Abdominal pain epigastric

2.9

27.7

180

651

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

27.7

387

2053

R03BA01

ATC

beclometasone; inhalant

1.9

27.6

466

2646

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.9

27.6

174

617

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.3

27.4

259

1156

C07AA05

ATC

propranolol; systemic

1.8

27.3

557

3367

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

27.3

328

1633

H02AB07

ATC

prednisone; oral

1.8

27.3

492

2861

ENC20

NOMESCO Finland

Myotomy of cricopharyngeal muscle

+∞

27.1

J01FF01

ATC

clindamycin; systemic

1.6

26.9

848

5805

N05BA12

ATC

alprazolam; oral

2.1

26.8

325

1626

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

26.7

1253

9416

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.9

26.7

114

302

JBC00

NOMESCO Finland

Gastro-oesophageal antireflux operation

97.4

26.7

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.2

26.6

296

1423

N05CF02

ATC

zolpidem; oral

1.8

26.5

529

3176

C01DA14

ATC

isosorbide mononitrate; oral

1.7

26.5

641

4081

JCA08

NOMESCO Finland

Endoscopic removal of foreign body from oesophagus

20.7

26.5

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

26.3

1302

9890

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.8

26.3

172

625

M79.1

ICD-10 Finland

Myalgia

2.0

26.3

374

1996

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

26.2

1193

8897

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

26.2

482

2818

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

26.1

548

3342

R05

ICD-10 Finland

Cough

1.7

26.1

595

3722

M01AH02

ATC

rofecoxib; oral

1.8

26.0

455

2611

JCA32

NOMESCO Finland

Endoscopic injection in oesophagus

60.4

26.0

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

5.1

25.9

166

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

25.8

1392

10752

1320

FHL

Esophagoscopy

13.9

25.8

K59.1

ICD-10 Finland

Functional diarrhoea

2.7

25.7

178

671

L01

ICPC

Neck symptom/complaint

1.9

25.7

392

2145

N06AB06

ATC

sertraline; oral

2.1

25.6

322

1632

N06AB10

ATC

escitalopram; oral

1.7

25.4

535

3264

M01AB55

ATC

diclofenac, combinations; oral

2.3

25.3

256

1179

JDB10

NOMESCO Finland

Percutaneous gastrostomy

5.5

25.1

138

5306A

ICD-9 Finland

Diseases of oesophagus, Diverticulum of oesophagus, acquired[DIVERTICULUM OESOPHAGI ZENKER]

+∞

25.0

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.4

24.9

221

953

ZXA00

NOMESCO Finland

Right side

1.5

24.9

922

6545

F10.24

ICD-10 Finland

Alcohol depence active use

6.3

24.7

106

K29.2

ICD-10 Finland

Alcoholic gastritis

90.7

24.7

R50.9

ICD-10 Finland

Fever, unspecified

1.8

24.7

452

2634

H02AB04

ATC

methylprednisolone; systemic

1.8

24.6

462

2715

N05BE01

ATC

buspirone; oral

3.8

24.6

108

294

K70.1

ICD-10 Finland

Alcoholic hepatitis

12.4

24.5

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

24.4

294

1463

G47.3

ICD-10 Finland

Sleep apnoea

1.7

24.4

640

4156

A01

ICPC

Pain general/multiple sites

2.2

24.4

262

1242

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

24.4

271

1304

N05BA02

ATC

chlordiazepoxide; systemic

3.9

24.3

103

272

R07.0

ICD-10 Finland

Pain in throat

2.6

24.2

180

707

N03AE01

ATC

clonazepam; systemic

2.5

24.1

201

839

A11

ICPC

Chest pain NOS

2.2

24.1

257

1213

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

24.0

717

4816

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.5

24.0

191

778

JDA55

NOMESCO Finland

Endoscopic dilatation of stomach, pylorus or anastomosis of stomach

37.8

23.9

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

23.9

645

4220

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

23.6

826

5772

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.3

23.5

224

1004

R05FB02

ATC

cough suppressants and expectorants

1.5

23.5

1207

9181

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.1

23.4

232

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

23.3

1095

8175

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

23.3

261

1261

1413

FHL

Laparoscopy and other therapeutic procedure

3.8

23.2

100

268

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

5.8

23.0

116

C07AB02

ATC

metoprolol; systemic

1.6

23.0

773

5346

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.5

22.9

185

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

22.9

219

984

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

7.5

22.8

E0000UV

ATC

1.5

22.8

1168

8868

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.2

22.8

253

1216

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

22.8

550

3485

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

22.7

1573

12670

J01MA06

ATC

norfloxacin; oral

1.8

22.6

441

2619

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

6.5

22.6

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

22.6

417

2434

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

6.3

22.6

B01AB05

ATC

enoxaparin; parenteral

1.5

22.5

980

7185

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

22.5

552

3511

N02AC04

ATC

dextropropoxyphene; oral

2.5

22.5

176

712

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

22.4

2027

17135

R03AC03

ATC

terbutaline; inhalant

1.8

22.4

417

2442

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

22.4

218

987

R60.0

ICD-10 Finland

Localized oedema

1.9

22.3

372

2096

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.9

22.3

139

491

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

22.2

348

1921

ZX120

NOMESCO Finland

Intravenous

2.0

22.1

308

1624

R96

ICPC

Asthma

2.1

22.1

268

1338

R4190

NOMESCO Finland

Nutritional therapy

3.3

22.0

113

349

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.4

22.0

197

857

GD1AD

NOMESCO Finland

Thorax CT examination

2.6

21.9

165

652

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.4

21.9

199

870

J01MA14

ATC

moxifloxacin; systemic

2.0

21.8

304

1605

R4110

NOMESCO Finland

Physiotherapy

1.5

21.7

839

5980

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.4

21.7

192

828

M54.2

ICD-10 Finland

Cervicalgia

2.2

21.7

219

1008

M01AH01

ATC

celecoxib; oral (coxibs)

1.6

21.6

566

3666

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.8

21.5

145

538

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.6

21.5

164

655

M01AX17

ATC

nimesulide; oral

1.5

21.4

776

5448

P15

ICPC

Chronic alcohol abuse

3.6

21.2

274

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

21.1

215

993

E87.6

ICD-10 Finland

Hypokalaemia

3.0

21.1

122

410

V03AA01

ATC

4.4

21.1

182

R06AX27

ATC

desloratadine; oral

1.6

21.1

672

4577

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.7

21.0

149

570

R52.9

ICD-10 Finland

Pain, unspecified

2.1

20.9

257

1290

R4130

NOMESCO Finland

Speech therapy

3.5

20.9

283

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

20.8

155

609

C10AC01

ATC

colestyramine; oral

3.6

20.8

263

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.6

20.7

159

637

L03

ICPC

Low back symptom/complaint

1.6

20.6

671

4589

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.3

20.6

190

836

K26.3

ICD-10 Finland

Duodenal ulcer, acute without haemorrhage or perforation

110.6

20.6

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

20.5

346

1956

R03AC12

ATC

salmeterol; inhalant

2.4

20.4

172

725

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

20.3

375

2184

K02.1

ICD-10 Finland

Caries of dentine

1.4

20.3

1589

12987

WX402

NOMESCO Finland

General anaesthesia

1.7

20.2

487

3074

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

20.1

806

5780

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.7

20.1

143

548

J45.8

ICD-10 Finland

Mixed asthma

3.1

20.1

114

377

R55

ICD-10 Finland

Syncope and collapse

1.8

19.9

387

2293

K26.7

ICD-10 Finland

Duodenal ulcer, chronic without haemorrhage or perforation

+∞

19.8

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.4

19.7

173

745

R00.2

ICD-10 Finland

Palpitations

2.3

19.6

194

886

X58

ICD-10 Finland

Exposure to other specified factors

1.7

19.5

402

2426

L28

ICPC

Limited function/disability (L)

1.6

19.5

528

3441

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.0

19.5

243

1229

R03AK08

ATC

formoterol and beclometasone; inhalant

3.0

19.5

117

403

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.7

19.4

139

534

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

19.4

443

2754

J01EA01

ATC

trimethoprim; systemic

1.5

19.4

762

5434

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.8

19.4

326

1841

M01AC06

ATC

meloxicam; systemic, rectal

1.4

19.3

1079

8271

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.2

19.3

104

334

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

16.8

19.1

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

4.9

19.1

127

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

19.1

275

1470

WX892

NOMESCO Finland

Monitored bed care

2.0

19.1

263

1383

N06AX03

ATC

mianserin; oral

2.4

19.1

166

709

Y0599

ICD-8 Finland

Investigation of digestive system

4.0

19.1

196

C08CA01

ATC

amlodipine; oral

1.4

19.1

1203

9427

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

19.0

475

3030

N05AB01

ATC

dixyrazine; systemic

5.5

19.0

103

L17

ICPC

Foot/toe symptom/complaint

1.5

19.0

745

5311

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.7

18.9

132

499

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

7.3

18.9

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

18.8

206

984

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

18.8

246

1268

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.1

18.8

107

356

M48.0

ICD-10 Finland

Spinal stenosis

1.7

18.7

404

2469

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.0

18.7

109

370

XQ800

NOMESCO Finland

Prick test

2.3

18.6

181

820

M34.1

ICD-10 Finland

CR(E)ST syndrome

18.8

18.6

D13.0

ICD-10 Finland

Benign neoplasm: Oesophagus

18.8

18.6

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

18.6

360

2129

D07AC01

ATC

betamethasone; topical

1.4

18.6

1044

7999

Z01.7

ICD-10 Finland

Laboratory examination

1.8

18.5

335

1941

M02AA07

ATC

piroxicam; topical

1.4

18.4

1151

8991

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

18.4

401

2457

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

2.1

18.4

210

1022

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

18.4

683

4802

R51

ICD-10 Finland

Headache

2.5

18.3

146

595

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

18.3

1477

12058

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

18.3

889

6617

N05AA02

ATC

levomepromazine; systemic

2.5

18.3

146

597

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

18.3

324

1863

B37.8

ICD-10 Finland

Candidiasis of other sites

19.4

18.2

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.2

18.1

189

883

B01AA03

ATC

warfarin; systemic

1.5

18.1

767

5548

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

4.3

18.1

158

SPAT1255

SPAT

Intravenous administration of medicine

2.1

18.1

223

1120

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

17.9

760

5498

N30.0

ICD-10 Finland

Acute cystitis

1.7

17.9

403

2493

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

17.9

259

1387

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

17.8

373

2255

UJC01

NOMESCO Finland

Scopy of lower throat

5.3

17.8

103

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

17.7

435

2758

M01AH05

ATC

etoricoxib; oral

1.4

17.7

1678

14046

5309X

ICD-9 Finland

Diseases of oesophagus, Unspecified disorder of oesophagus

+∞

17.7

JBW97

NOMESCO Finland

Other laparoscopic operation on diaphragm or laparoscopic or thoracoscopic operation for gastro-oesophageal reflux

+∞

17.7

W19

ICD-10 Finland

Unspecified fall

1.8

17.7

303

1721

M01AE02

ATC

naproxen; oral, rectal

1.4

17.7

1639

13670

ZXA10

NOMESCO Finland

Bilateral

1.5

17.6

585

4003

R10.0

ICD-10 Finland

Acute abdomen

2.9

17.6

107

373

NF1AA

NOMESCO Finland

Hip X-ray examination

1.8

17.6

295

1666

R03BA08

ATC

ciclesonide; inhalant

2.0

17.6

228

1169

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.3

17.5

164

729

Z71.8

ICD-10 Finland

Other specified counselling

1.5

17.5

662

4672

A06AC51

ATC

ispaghula, combinations; systemic

2.4

17.5

154

666

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

5.6

17.2

JAH00

NOMESCO Finland

Laparotomy

2.9

17.1

104

363

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.2

17.0

179

839

N03AF01

ATC

carbamazepine; oral, rectal

2.2

17.0

179

841

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.6

17.0

125

490

A04

ICPC

Weakness/tiredness general

1.7

17.0

399

2495

K44.0

ICD-10 Finland

Diaphragmatic hernia with obstruction, without gangrene

11.6

17.0

R20.2

ICD-10 Finland

Paraesthesia of skin

2.2

16.9

184

878

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.4

16.9

142

599

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

16.9

956

7304

M01AB05

ATC

diclofenac; systemic, rectal

1.3

16.9

2014

17433

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

16.9

150

652

J46

ICD-10 Finland

Status asthmaticus

3.2

16.8

273

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.9

16.8

248

1336

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

4.9

16.7

111

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.0

16.7

215

1100

5356X

ICD-9 Finland

Gastritis and duodenitis, Duodenitis

+∞

16.7

5353A

ICD-9 Finland

Gastritis and duodenitis, Alcoholic gastritis

+∞

16.7

53503

ICD-8 Finland

Gastritis and duodenitis, Gastritis chronica NUD

+∞

16.7

53508

ICD-8 Finland

Gastritis and duodenitis, Gastroduodenitis NUD

+∞

16.7

5301X

ICD-9 Finland

Diseases of oesophagus, Oesophagitis[OESOPHAGITIS NUD]

+∞

16.7

6218

FHL

Other esophageal surgery of neck area (eg divertekkel)

+∞

16.7

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.2

16.6

275

K44

ICD-10 Finland

Diaphragmatic hernia

7.7

16.6

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

16.6

738

5382

JN4BD

NOMESCO Finland

Extensive body CT

1.7

16.5

358

2189

1323

FHL

Esophagoscopy and dilatation

170.6

16.5

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

16.5

331

1979

J45

ICD-10 Finland

Asthma

1.9

16.5

269

1503

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

18.0

16.4

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

16.4

809

6019

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.0

16.4

217

1122

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

16.3

831

6220

F45.8

ICD-10 Finland

Other somatoform disorders

2.3

16.3

159

723

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

16.2

320

1901

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

16.2

269

1512

TJD20

NOMESCO Finland

Change of gastrostomy tube

10.4

16.1

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.1

16.1

183

890

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

16.1

314

1860

L04AA06

ATC

mycophenolic acid; systemic

3.9

16.1

172

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.5

16.0

125

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.4

16.0

142

617

SPAT1301

SPAT

No procedures

1.4

16.0

982

7606

Z01.2

ICD-10 Finland

Dental examination

1.4

16.0

1084

8544

D06

ICPC

Abdominal pain localized other

2.0

16.0

214

1114

R35

ICD-10 Finland

Polyuria

2.0

15.9

214

1115

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.2

15.9

164

764

ZXA05

NOMESCO Finland

Left side

1.4

15.9

820

6149

D11

ICPC

Diarrhoea

1.8

15.9

278

1590

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

7.1

15.8

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

6.4

15.8

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.7

15.7

107

402

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

15.7

707

5158

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

15.7

1939

16785

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

15.6

226

1211

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

9.8

15.6

5322A

ICD-9 Finland

Duodenal ulcer, Acute with haemorrhage and perforation[ULCUS BULBI,KOMPLISOITUMATON]

+∞

15.6

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

15.6

190

951

WX290

NOMESCO Finland

Other blockade of nerve

1.4

15.6

1109

8801

SPAT1104

SPAT

Monitoring of emergency patient

2.0

15.6

215

1131

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

15.5

814

6120

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

15.5

1210

9749

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

4.9

15.5

103

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

15.5

315

1891

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

5.0

15.4

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.5

15.4

118

472

D03

ICPC

Heartburn

3.0

15.4

302

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.7

15.3

104

390

R01AD12

ATC

fluticasone furoate; nasal

1.4

15.3

713

5239

EBA00

NOMESCO Finland

Extraction of tooth

1.4

15.3

932

7198

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.4

15.3

127

533

R49.01

ICD-10 Finland

Functional dysphonia

2.9

15.3

325

SPAT1236

SPAT

Informing family of child’s disability

3.0

15.2

291

D84

ICPC

Oesophagus disease

16.1

15.2

R03AC13

ATC

formoterol; inhalant

2.2

15.2

157

733

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

15.2

202

1048

A02BDXX

ATC

2.6

15.2

110

428

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

15.2

572

4018

XX9XE

NOMESCO Finland

Other ultrasound examination

6.4

15.2

A01AB04

ATC

amphotericin B; local oral

2.1

15.1

168

811

Z50.1

ICD-10 Finland

Other physical therapy

2.1

15.0

179

888

H53.1

ICD-10 Finland

Subjective visual disturbances

2.1

15.0

181

903

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

14.9

1754

15020

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.9

14.9

218

1174

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

14.9

253

1432

Z72.1

ICD-10 Finland

Alcohol use

4.3

14.9

126

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.9

14.8

155

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

14.8

1017

8013

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

14.7

181

910

A03DA02

ATC

pitofenone and analgesics; systemic

3.1

14.7

261

L04AX01

ATC

azathioprine; systemic

2.5

14.7

118

488

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

14.7

533

3713

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

14.7

312

1896

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

14.7

488

3332

S18

ICPC

Laceration/cut

1.3

14.6

1289

10560

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

14.6

358

2263

5301B

ICD-9 Finland

Diseases of oesophagus, Oesophagitis[BARRETT'S OESOPHAGUS]

+∞

14.6

5350A

ICD-9 Finland

Gastritis and duodenitis, Acute gastritis

+∞

14.6

Z01.9

ICD-10 Finland

Special examination, unspecified

2.1

14.6

171

843

SPAT1097

SPAT

Recording of ECG

1.5

14.6

477

3243

R06AX13

ATC

loratadine; oral

1.6

14.6

384

2475

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.7

14.5

306

1855

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

8.1

14.5

R05

ICPC

Cough

1.5

14.5

603

4325

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

14.5

1553

13104

XKD00

NOMESCO Finland

Uroflowmetry

1.5

14.4

567

4017

M54.6

ICD-10 Finland

Pain in thoracic spine

2.1

14.4

172

854

J31.0

ICD-10 Finland

Chronic rhinitis

1.9

14.4

202

1070

S29

ICPC

Skin symptom/complaint other

1.5

14.4

492

3380

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.2

14.4

154

732

J01CA08

ATC

pivmecillinam; oral

1.4

14.4

1012

7996

P74

ICPC

Anxiety disorder/anxiety state

3.0

14.3

288

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.5

14.3

634

4601

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

6.0

14.3

XG410

NOMESCO Finland

Flow-volume spirometry

2.3

14.3

133

592

R03AK11

ATC

formoterol and fluticasone; inhalant

3.2

14.3

244

L13

ICPC

Hip symptom/complaint

1.6

14.3

448

3018

5780A

ICD-9 Finland

Gastro-intestinal haemorrhage, Haematemesis

17.0

14.3

R21

ICPC

Throat symptom/complaint

1.6

14.3

439

2942

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

14.2

346

2183

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

14.2

253

1458

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

6.8

14.2

127

Kela drug reimbursment

Transplant complication

3.9

14.1

147

W10

ICD-10 Finland

Fall on and from stairs and steps

2.1

14.1

152

724

SPAT1153

SPAT

Removal of sutures

1.4

14.1

976

7682

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

14.1

739

5543

R03DA04

ATC

theophylline; systemic, rectal

1.9

14.1

197

1042

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

14.1

689

5101

S22.3

ICD-10 Finland

Fracture of rib

1.9

14.0

205

1103

N01

ICPC

Headache

1.8

14.0

233

1308

Z71.9

ICD-10 Finland

Counselling, unspecified

2.1

14.0

165

816

UJF02

NOMESCO Finland

Peroral enteroscopy

8.4

14.0

SPAT1260

SPAT

Consultation of another employee

1.5

13.9

526

3693

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.0

13.9

179

916

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.3

13.9

211

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

15.8

13.9

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.0

13.9

173

876

K70.4

ICD-10 Finland

Alcoholic hepatic failure

12.7

13.9

M05BA04

ATC

alendronic acid; oral

1.8

13.8

262

1535

Z50.5

ICD-10 Finland

Speech therapy

4.3

13.8

121

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

13.8

402

2654

XG466

NOMESCO Finland

Sleep oxymetry

2.5

13.8

108

438

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

53.5

13.8

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

13.8

270

1601

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

4.0

13.8

136

D13.3

ICD-10 Finland

Benign neoplasm: Other and unspecified parts of small intestine

10.5

13.7

A41.9

ICD-10 Finland

Sepsis, unspecified

2.3

13.6

128

572

D10

ICPC

Vomiting

2.3

13.6

128

572

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.6

13.6

101

400

A02BX05

ATC

bismuth subcitrate; oral

3.8

13.6

152

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.4

13.6

116

493

5303A

ICD-9 Finland

Diseases of oesophagus, Stricture and stenosis of oesophagus[STRICTURA ET STENOSIS OESOPHAGI]

+∞

13.5

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.7

13.5

353

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

4.6

13.5

101

R30.0

ICD-10 Finland

Dysuria

2.5

13.5

103

413

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

13.5

266

1580

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

13.4

437

2963

C03DA01

ATC

spironolactone; oral

1.6

13.4

346

2216

SPAT1240

SPAT

Therapeutic discussion

1.8

13.4

239

1376

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

3.0

13.4

260

XF404

NOMESCO Finland

Ambulatory ECG

1.7

13.4

290

1769

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

13.4

235

1348

A07EC02

ATC

mesalazine; oral, rectal

2.1

13.3

148

712

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.2

13.3

136

631

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

13.3

166

838

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

13.3

665

4934

J01DA06

ATC

[U] cefuroxime; systemic

1.6

13.3

412

2764

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.1

13.3

155

765

G04BD04

ATC

oxybutynin; oral, transdermal

1.9

13.2

184

975

G43.9

ICD-10 Finland

Migraine, unspecified

2.3

13.1

117

512

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

13.1

1047

8417

P03

ICPC

Feeling depressed

1.9

13.1

189

1012

49300

ICD-8 Finland

Asthma, bronchiale

2.7

13.0

343

1370

FHL

Colonoscopy, whole colon

7.1

13.0

E000001

ATC

1.5

13.0

576

4176

M79.7

ICD-10 Finland

Fibromyalgia

3.0

13.0

255

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

12.9

247

1456

N06AA06

ATC

trimipramine; systemic

2.8

12.9

292

K85

ICD-10 Finland

Acute pancreatitis

3.1

12.9

224

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.6

12.9

346

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.1

12.9

152

754

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.5

12.9

102

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.9

12.8

258

N04BC05

ATC

pramipexole; oral

1.8

12.8

223

1276

A28

ICPC

Limited function/disability NOS

1.5

12.7

503

3560

J20

ICD-10 Finland

Acute bronchitis

1.7

12.7

262

1577

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.2

12.7

124

564

J01FA01

ATC

erythromycin; systemic

1.6

12.7

340

2201

I73.0

ICD-10 Finland

Raynaud syndrome

3.8

12.7

137

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768797) Stomach Pathology biopsy report

1254

2733

6.21

307.65

1.6

1.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1657

9092

2.40

150.45

3.7

2.3

55.9

58.8

u/l

2.07

1554

8349

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2394

15809

2.27

135.25

7.0

6.0

11.8

12.2

umol/l

0.52

2290

14992

(3032080) INR in Blood by Coagulation assay

2046

13401

2.07

108.84

12.0

10.3

1.3

inr

2.69

639

3832

(3024561) Albumin [Mass/volume] in Serum or Plasma

2045

13703

2.00

98.67

5.9

4.5

34.7

35.0

g/l

2.15

1914

12631

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1310

7775

2.02

86.46

2.7

2.1

3.1

3.0

mg/l

1.05

1128

6566

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3025

23871

2.08

84.99

9.8

7.2

81.4

79.8

u/l

0.53

2905

22336

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1816

12134

1.91

83.74

5.5

3.7

101.5

90.9

ng/l

0.07

1367

8885

(3013826) Glucose [Moles/volume] in Serum or Plasma

2505

18641

1.91

81.98

6.7

4.5

6.8

mmol/l

0.45

2410

17465

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1801

12068

1.89

81.70

3.6

2.7

135.8

148.7

ug/l

1.20

1625

11036

(42870588) Differential panel, method unspecified - Blood

1588

10223

1.91

81.44

6.7

5.5

—

(3013115) Eosinophils [#/volume] in Blood

2166

15422

1.88

80.93

7.0

5.7

0.2

e9/l

0.31

1902

13303

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2222

15958

1.88

80.69

8.6

6.5

1.2

mmol/l

1.01

1855

13374

(3006315) Basophils [#/volume] in Blood

2102

14899

1.86

78.90

6.9

5.5

0.0

e9/l

0.17

1843

12705

(3001604) Monocytes [#/volume] in Blood

2089

14829

1.85

77.52

6.8

5.5

0.6

e9/l

0.26

1831

12628

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2036

14393

1.84

76.03

7.8

5.8

1.2

mmol/l

2.04

1850

12967

(3019198) Lymphocytes [#/volume] in Blood

2128

15253

1.84

75.92

6.9

5.6

1.8

1.9

e9/l

1.28

1867

13221

(3019069) Monocytes/100 leukocytes in Blood

1996

14031

1.84

75.85

7.5

6.0

8.7

8.8

0.71

1879

13095

(3006504) Eosinophils/100 leukocytes in Blood

1987

13953

1.84

75.73

7.2

5.7

2.9

2.8

0.13

1864

12975

(3022096) Basophils/100 leukocytes in Blood

1941

13560

1.83

74.97

7.3

5.8

0.7

0.14

1824

12623

(3013650) Neutrophils [#/volume] in Blood by Automated count

2355

17520

1.83

73.30

9.5

8.6

4.3

4.2

e9/l

0.55

2070

15106

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1483

9626

1.86

71.84

2.7

2.1

176.5

227.0

u/l

2.04

1406

8960

(3002030) Lymphocytes/100 leukocytes in Blood

2014

14379

1.80

71.01

7.4

5.9

25.9

26.8

3.35

1885

13333

(3018010) Neutrophils/100 leukocytes in Blood

1982

14141

1.79

69.50

7.1

5.7

59.0

58.1

2.48

1861

13189

(3022948) Iron [Moles/volume] in Serum or Plasma

882

4861

2.04

69.22

3.0

2.5

11.8

12.8

umol/l

3.93

808

4491

(3003458) Phosphate [Moles/volume] in Serum or Plasma

775

4080

2.11

68.77

6.6

5.6

1.0

mmol/l

0.05

731

3762

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1857

13035

1.79

68.50

2.3

2.0

93.2

93.4

pmol/l

0.06

1015

6758

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1425

9284

1.83

67.12

4.1

3.0

33.2

38.5

u/l

1.48

1365

8782

(3044640) Blood type and Crossmatch panel - Blood

1467

9672

1.81

66.23

3.1

2.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1051

6243

1.92

66.03

1.9

1.8

1154.3

1173.2

nmol/l

0.26

796

4621

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2452

18821

1.78

65.01

4.3

2.9

59.4

51.2

u/l

3.32

2281

17283

(3004789) Transferrin [Mass/volume] in Serum or Plasma

821

4500

2.04

64.96

3.0

2.5

2.3

g/l

1.62

745

4152

(3023368) Bacteria identified in Blood by Culture

1408

9232

1.81

64.30

5.4

4.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2619

20597

1.78

62.71

6.6

4.5

408.9

1990.1

e6/l

2.65

353

(3037522) Nuclear Ab [Titer] in Serum

681

3531

2.12

62.35

1.4

1.3

657.3

492.2

titre

1.32

166

713

(3013707) Erythrocyte sedimentation rate by Westergren method

2795

22432

1.81

62.13

5.5

3.8

14.0

13.2

mm/h

1.64

2599

20575

(3048689) Calprotectin [Mass/mass] in Stool

580

2839

2.22

61.41

2.3

2.1

169.5

157.7

ug/g

0.24

451

2218

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

486

2219

2.35

60.68

2.0

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

572

2806

2.21

60.16

2.5

2.0

0.2

g/l

0.69

525

2597

(3026782) Osmolality of Urine

1055

6450

1.86

59.69

3.5

2.7

524.1

556.5

mosm/kgh2o

5.19

927

5476

(3037467) Urinalysis macro (dipstick) panel - Urine

2667

21290

1.75

58.36

6.0

4.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1732

12298

1.72

58.30

2.7

2.1

77.4

78.1

nmol/l

0.43

1553

10853

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1949

14302

1.70

57.98

5.2

4.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

759

4231

1.98

56.43

3.1

2.5

21.0

22.7

2.33

618

3593

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1031

6353

1.84

56.38

1.9

1.7

1.1

1.3

mg/l

2.79

796

4911

(3012095) Magnesium [Moles/volume] in Serum or Plasma

869

5107

1.89

55.03

4.2

3.0

0.8

mmol/l

1.91

819

4704

(3000570) Elastase.pancreatic [Mass/mass] in Stool

226

741

3.17

53.86

1.5

1.4

258.8

274.5

ug/g

0.51

138

434

(3002582) Erythrocytes [#/volume] in Urine

1440

9960

1.69

51.70

4.5

3.2

51.0

103.0

e6/l

2.16

1185

7645

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

605

3212

2.04

51.20

3.0

2.6

8.2

9.7

umol/l

0.75

520

2805

(3000850) Epithelial cells [#/volume] in Urine

1086

6971

1.76

50.94

3.5

2.6

5.6

5.1

e6/l

0.64

979

6102

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1436

9983

1.68

50.22

3.6

3.1

1873.2

1757.2

ng/l

0.32

1260

8619

(3018095) Leukocytes [#/volume] in Urine

1597

11413

1.66

50.21

5.1

3.7

132.2

112.4

e6/l

0.22

1240

8162

(3022145) Colonoscopy Study observation

570

3028

2.03

47.95

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1143

7569

1.71

47.36

1.8

1.5

20.5

20.0

nmol/l

0.45

989

6438

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

892

5505

1.80

47.36

1.3

1.2

1.7

1.9

u/ml

0.13

222

1419

(3026008) Bacteria identified in Urine by Culture

1393

9721

1.66

47.33

3.9

3.2

—

(3018418) pH of Serum or Plasma

1373

9597

1.65

46.06

5.1

3.9

7.4

0.04

293

1830

(3007164) IgA [Mass/volume] in Serum or Plasma

802

4847

1.82

45.44

1.6

1.4

2.8

2.5

g/l

1.36

473

2856

(3027945) Reticulocytes/100 erythrocytes in Blood

655

3725

1.91

44.97

2.7

2.4

1.9

1.7

2.30

571

3288

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

866

5407

1.77

43.75

2.1

1.8

—

(3015736) pH of Urine

1596

11699

1.60

43.49

4.3

3.4

—

5.9

—

(3030467) Casts [#/volume] in Urine by Automated count

1300

9072

1.64

43.28

4.2

3.1

0.3

0.5

e6/l

4.76

1046

6835

(36304419) Bacteria [Presence] in Urine

1264

8775

1.64

42.88

4.2

3.1

—

(3000494) Fungus identified in Specimen by Culture

592

3338

1.91

41.46

1.7

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

503

2685

2.00

41.39

3.4

2.3

42.9

40.9

u/l

0.09

436

2287

(3035350) Ketones [Presence] in Urine by Test strip

1947

15101

1.56

40.64

5.0

3.6

0.0

estimate

0.00

395

2885

(3036481) Cortisol [Moles/volume] in Serum or Plasma

470

2496

2.00

39.13

2.4

2.2

371.8

377.8

nmol/l

0.20

430

2282

(3033658) Prothrombin time (PT) actual/Normal

1136

7822

1.63

39.12

5.7

3.7

84.8

86.9

1.73

1103

7629

(3020779) Urea [Moles/volume] in Serum or Plasma

525

2900

1.93

38.97

7.9

6.9

10.5

10.7

mmol/l

0.16

502

2741

(3009261) Glucose [Presence] in Urine by Test strip

1959

15311

1.54

38.84

5.1

3.6

0.0

estimate

1.08

391

2823

(3021601) Nitrite [Presence] in Urine by Test strip

1937

15120

1.54

38.50

6.8

4.8

0.0

estimate

0.40

413

2905

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2680

22495

1.57

38.16

4.3

3.8

15.0

14.9

pmol/l

0.60

2433

20180

(3013512) EKG study

1282

9150

1.59

37.75

5.3

4.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

396

2002

2.08

37.69

2.5

2.7

10.2

10.5

g/l

0.87

358

1812

(3014576) Chloride [Moles/volume] in Serum or Plasma

682

4130

1.78

37.68

7.9

6.6

103.9

104.4

mmol/l

1.68

668

4027

(3023183) Ammonium ion [Moles/volume] in Plasma

169

588

2.96

36.28

3.4

2.2

32.7

34.2

umol/l

0.25

148

490

(40758558) Short blood count panel - Blood

1089

7550

1.61

35.90

7.0

6.5

—

(3027801) Oxygen [Partial pressure] in Arterial blood

636

3837

1.78

35.40

7.7

6.8

11.3

12.1

kpa

4.24

611

3646

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

636

3838

1.78

35.37

7.7

6.8

5.1

kpa

0.39

615

3653

(3025941) Bacteria identified in Stool by Culture

309

1454

2.22

35.28

1.3

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1064

7370

1.60

35.07

3.0

2.3

—

(3021589) Normoblasts [#/volume] in Blood

1754

13580

1.52

35.05

13.5

9.5

0.0

e9/l

0.58

1475

11041

(3003396) Base excess in Arterial blood by calculation

632

3826

1.77

34.71

7.8

6.8

1.4

1.1

mmol/l

1.07

520

2949

(3016502) Oxygen saturation in Arterial blood

582

3450

1.80

34.30

8.0

7.1

94.9

95.5

1.29

568

3320

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

940

6366

1.62

33.81

5.0

3.7

276.1

604.1

ng/l

1.40

777

5247

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

202

802

2.60

33.71

1.8

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

998

6887

1.60

33.10

1.8

1.7

440.7

29444670.2

pmol/l

5.01

807

5614

(3015377) Calcium [Moles/volume] in Serum or Plasma

1434

10733

1.52

33.08

3.3

3.4

2.3

2.4

mmol/l

2.09

1221

9324

(3005322) IgE [Units/volume] in Serum or Plasma

312

1514

2.15

32.94

1.5

1.2

290.2

246.1

u/ml

0.17

294

1377

(3022217) INR in Platelet poor plasma by Coagulation assay

717

4565

1.69

32.70

28.4

28.1

1.5

inr

0.22

639

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

613

3743

1.75

32.52

2.0

1.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

314

1537

2.13

32.41

1.9

1.7

1.4

g/l

0.52

285

1383

(3023520) Reticulocytes [#/volume] in Blood

492

2818

1.85

32.32

2.5

70.8

67.7

e9/l

0.92

349

2090

(3018677) aPTT in Platelet poor plasma by Coagulation assay

770

5012

1.66

32.24

2.3

2.0

30.7

30.1

1.55

744

4864

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3399

30672

1.70

31.54

25.8

14.6

24.3

26.3

mg/l

2.92

2993

24458

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

365

1919

1.99

31.00

1.6

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

606

3742

1.73

30.76

2.0

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

582

3554

1.75

30.74

2.0

1.8

—

(3012544) pH of Venous blood

531

3159

1.78

30.70

4.6

3.5

7.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

514

3041

1.79

30.25

4.6

3.5

5.8

kpa

0.01

494

2938

(3002032) Base excess in Venous blood by calculation

514

3043

1.79

30.18

4.6

3.5

1.9

2.0

mmol/l

0.23

425

2425

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

706

4569

1.66

30.01

1.3

1.2

33.1

35.7

iu/ml

0.19

246

1405

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

773

5134

1.63

29.61

3.6

3.0

2.0

2.3

e6/l

0.52

462

2756

(3014111) Lactate [Moles/volume] in Serum or Plasma

489

2883

1.79

29.06

7.6

6.6

1.4

mmol/l

0.65

472

2774

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

351

1861

1.97

29.05

4.4

3.5

2.2

1.9

mmol/l

0.52

270

1315

(3042936) Bacteria identified in Isolate by Culture

683

4420

1.66

28.94

2.5

1.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

470

2745

1.81

28.82

2.2

2.6

65.6

66.1

g/l

0.60

422

2484

(3009343) pH of Capillary blood

359

1924

1.95

28.79

4.4

3.5

7.4

0.31

250

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

594

3716

1.70

28.60

3.4

4.2

242.0

250.0

u/l

0.65

557

3508

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

300

1513

2.06

28.55

2.6

2.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

109

339

3.28

28.35

1.7

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

176

717

2.52

27.85

2.5

2.1

127.6

129.3

g/l

0.34

140

527

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1495

11586

1.46

27.70

5.3

3.9

—

(1616796) Gas panel - Central venous blood

179

739

2.49

27.54

3.8

3.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

359

1954

1.92

27.46

4.5

3.5

5.2

5.1

kpa

0.71

338

1783

(3002173) Hemoglobin [Mass/volume] in Arterial blood

518

3170

1.73

26.93

8.5

7.5

119.1

121.6

g/l

1.91

503

3053

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

229

1070

2.21

26.53

3.0

2.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3095

27632

1.52

26.47

5.4

4.5

2.7

2.1

mu/l

0.31

2844

24922

(40760892) CBC W Ordered Manual Differential panel - Blood

900

6350

1.54

26.16

5.1

4.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

216

995

2.24

25.90

1.3

1.2

1.7

1.0

u/ml

0.34

(3041096) Erythrocytes [Presence] in Urine by Automated

1088

8021

1.49

25.54

5.0

3.3

—

(3000991) Gas panel - Venous blood

449

2679

1.76

25.46

9.7

8.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

289

1501

2.00

25.31

1.8

1.7

1.5

1.6

g/l

1.02

250

1285

(40768804) Tissue Pathology biopsy report

1535

12112

1.43

25.13

2.3

2.2

—

(4010399)

357

2005

1.86

24.72

1.5

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

790

5498

1.54

24.21

3.4

2.8

1.0

1.2

e6/l

0.93

476

3090

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

651

4335

1.60

24.20

1.3

1.2

20.4

14.2

u/ml

0.37

240

1645

(3026493) Urate [Moles/volume] in Serum or Plasma

1107

8262

1.47

24.18

3.3

2.7

4471.4

5573.9

umol/l

0.37

942

7068

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

182

803

2.33

24.17

2.2

1.5

1.2

g/l

0.56

172

761

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

176

778

2.32

23.28

2.2

1.5

0.2

g/l

0.85

167

739

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

483

3012

1.69

23.25

2.2

1.7

1.6

1.5

1.05

399

2619

(3019060) Gas panel - Arterial blood

379

2211

1.79

23.14

4.9

4.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

416

2504

1.74

22.78

4.0

2.8

4.3

4.5

kpa

1.17

398

2410

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

135

534

2.58

22.74

8.9

4.2

585.2

3993.2

iu/ml

0.57

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

284

1529

1.92

22.37

5.0

3.7

23.9

24.2

mmol/l

0.50

248

1364

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

397

2374

1.75

22.23

4.2

3.7

102.4

94.9

ng/l

0.55

330

2007

(3013139) Helicobacter pylori Ag [Presence] in Stool

283

1528

1.92

22.10

1.3

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

193

907

2.18

22.04

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

361

2110

1.78

21.87

7.3

6.4

25.0

24.5

mmol/l

1.61

338

1969

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

596

3975

1.59

21.83

1.6

1.4

—

(3019150) Specific gravity of Urine by Refractometry

908

6636

1.48

21.70

5.3

4.1

1.0

kg/l

2.28

202

945

(3003327) Ova and parasites identified in Stool by Light microscopy

167

755

2.26

20.97

1.9

1.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

462

2966

1.63

19.71

2.6

2.3

8.0

7.7

ug/l

0.06

379

2563

(40767503) Oxygen content in Capillary blood by calculation

157

710

2.26

19.71

3.0

2.4

16.2

16.1

0.13

356

(3007566) Smooth muscle Ab [Titer] in Serum

149

661

2.30

19.58

1.2

78.3

95.6

titre

0.29

(3028626) Oxygen [Partial pressure] in Capillary blood

159

730

2.23

19.26

3.4

2.9

8.1

7.9

kpa

0.67

154

672

(3024980) IgG subclass 4 [Mass/volume] in Serum

101

379

2.71

18.95

1.5

0.8

0.9

g/l

0.44

285

(3030981) Hyaline casts [#/volume] in Urine by Automated count

301

1745

1.78

18.70

3.7

2.8

0.3

e6/l

0.06

294

1705

(3000492) Spirometry study

410

2591

1.65

18.59

1.7

1.4

—

(3012501) Base excess in Blood by calculation

158

740

2.18

18.23

5.1

4.5

2.8

2.7

mmol/l

0.26

122

496

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

520

3499

1.56

18.12

5.1

3.5

—

(3010421) pH of Blood

175

857

2.09

18.01

5.1

4.3

7.4

0.52

156

722

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

151

698

2.21

18.00

1.7

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

299

1750

1.77

17.97

9.8

9.1

24.8

24.3

mmol/l

1.18

277

1613

(3004588) Protein electrophoresis panel - Serum or Plasma

364

2259

1.67

17.68

2.1

2.4

—

(36660697) Celiac disease serology panel - Serum

327

1979

1.71

17.45

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

302

1789

1.74

17.40

8.8

9.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

431

2805

1.60

17.31

1.7

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1979

16941

1.33

17.22

3.2

2.6

—

(3021901) Oxygen saturation in Capillary blood

136

617

2.25

16.98

3.2

2.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

454

3007

1.57

16.90

3.5

2.9

207.8

227.8

ng/l

0.48

419

2745

(3019550) Sodium [Moles/volume] in Serum or Plasma

3434

32071

1.48

16.85

28.6

17.2

139.3

139.7

mmol/l

10.37

3366

31182

(3015235) Bicarbonate [Moles/volume] in Capillary blood

168

838

2.05

16.48

3.6

3.1

25.5

24.9

mmol/l

1.03

157

726

(3023103) Potassium [Moles/volume] in Serum or Plasma

3436

32161

1.47

16.00

28.7

17.4

4.0

mmol/l

1.67

3357

31225

(3017181) Myelocytes/100 leukocytes in Blood

402

2627

1.59

15.82

4.4

3.9

1.0

0.9

0.26

122

767

(46235355) HIV 1 and 2 tests - Meaningful Use set

565

3978

1.49

15.80

1.9

1.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

415

2736

1.58

15.73

4.9

3.9

1.2

mmol/l

1.51

368

2355

(3023419) Bacteria identified in Sputum by Culture

396

2.48

15.40

2.7

2.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

483

3313

1.52

15.29

3.4

4.1

13.8

24.9

ug/l

0.87

410

2726

(3029937) Albumin [Presence] in Urine by Test strip

1058

8369

1.36

15.23

5.4

4.0

0.0

estimate

0.46

396

2756

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

180

947

1.94

15.20

2.1

1.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

206

1134

1.86

15.16

2.5

2.4

356.7

520.7

ug/l

0.80

191

1074

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

478

3278

1.52

15.15

1.7

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

237

1367

1.78

14.98

2.0

1.9

3.1

2.5

ug/l

0.21

209

1190

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

217

1221

1.82

14.89

1.1

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

156

788

2.02

14.81

1.1

—

(3003181) Sodium [Moles/volume] in Urine

118

536

2.24

14.74

1.6

1.3

53.9

62.1

mmol/l

1.46

430

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

155

783

2.02

14.71

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

156

795

2.00

14.45

1.1

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

138

677

2.07

14.19

1.4

1.2

14.3

41.0

u/ml

—

(3021440) Promyelocytes/100 leukocytes in Blood

380

2514

1.56

14.15

4.4

3.9

0.1

0.14

108

717

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

316

2001

1.63

14.14

1.8

1.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

154

789

1.99

14.06

2.5

1.7

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

233

1365

1.75

13.96

4.4

4.7

1.7

1.6

0.42

223

1276

(3042631) Mycobacterium sp identified in Specimen

103

457

2.29

13.63

2.9

2.8

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

331

2.51

13.39

3.9

3.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

113

527

2.18

13.27

1.4

1.2

6.3

u/ml

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

128

633

2.06

12.92

1.2

1.1

13.7

6.8

u/ml

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

287

1819

1.62

12.80

2.4

29.3

23.0

au/ml

0.27

(40761511) CBC panel - Blood by Automated count

3373

31740

1.39

12.73

24.1

13.8

—

(3022313) Gas panel - Capillary blood

228

1364

1.71

12.69

4.9

3.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

265

1650

1.65

12.68

1.3

29.9

59.9

au/ml

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

307

1986

1.59

12.58

3.8

3.0

124.5

128.6

g/l

2.14

298

1937

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

199

1151

1.77

12.49

5.3

3.8

24.9

24.8

mmol/l

0.24

185

1032

(3027135) IgG subclass 1 [Mass/volume] in Serum

231

2.75

12.48

1.2

1.3

6.8

7.1

g/l

0.26

160

(3028192) IgG subclass 2 [Mass/volume] in Serum

231

2.75

12.48

1.2

1.3

3.1

2.9

g/l

0.48

160

(3024139) IgG subclass 3 [Mass/volume] in Serum

231

2.75

12.48

1.2

1.3

0.4

g/l

0.42

163

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

138

711

1.97

12.44

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

138

711

1.97

12.44

1.5

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

4.85

12.36

2.4

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

439

2.24

12.28

1.3

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

105

491

2.17

12.27

1.4

1.2

51.5

41.0

u/ml

0.22

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

4.93

12.14

1.0

—

(3025159) Blasts/100 leukocytes in Blood

351

2360

1.53

12.13

4.4

3.9

0.0

0.3

1.08

605

(3019225) pH of Specimen

438

3087

1.47

12.04

5.3

4.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

904

7198

1.33

12.01

4.4

3.6

—

(4062490)

236

2.70

11.99

1.2

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

785

6129

1.35

11.90

3.1

2.5

mmol/l

0.23

670

5382

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

120

599

2.03

11.84

3.4

3.5

59.8

57.9

0.84

120

599

(3007930) Methemoglobin/Hemoglobin.total in Blood

223

1354

1.68

11.77

4.4

4.8

0.9

0.33

213

1268

(40761536) Microorganisms panel - Urine sediment

384

2649

1.50

11.75

5.7

3.9

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

116

574

2.05

11.72

2.9

3.2

4.3

4.2

e9/l

0.11

116

574

(3038177) Helicobacter pylori Ab [Presence] in Serum

348

2.35

11.60

1.3

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3091

28834

1.31

11.38

22.3

14.2

77.2

77.3

ml/min/173m2

0.11

2685

23696

(3039162) Centromere protein B Ab [Units/volume] in Serum

308

2.43

11.37

1.4

1.2

111.8

30.6

u/ml

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

123

630

1.98

11.31

1.4

1.2

9.4

2.4

u/ml

0.84

(3048929) Epstein Barr virus Ab [Presence] in Serum

132

693

1.94

11.30

1.3

1.2

—

(4094501)

141

759

1.89

11.20

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

106

517

2.08

11.15

3.5

3.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

194

2.81

11.15

1.8

1.3

2.1

1.1

promille

2.87

151

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

122

629

1.97

11.02

1.5

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

123

636

1.96

11.02

1.4

1.2

6.2

6.9

u/ml

0.09

106

(3020491) Glucose [Moles/volume] in Blood

201

2.76

11.00

1.7

2.4

6.7

6.8

mmol/l

0.10

133

(40761535) Cells panel - Urine sediment

382

2667

1.48

11.00

3.8

3.4

—

(3044889) 12 lead EKG panel

2445

22201

1.26

10.92

5.0

3.9

—

(3012516) Albumin [Mass/volume] in Urine

1161

9669

1.28

10.86

3.5

3.2

861.9

293.4

mg/l

2.13

770

6204

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

197

1186

1.69

10.75

1.9

1.8

39.4

39.1

u/l

0.06

175

1023

(3009508) Creatinine [Moles/volume] in Urine

1204

10087

1.28

10.71

3.4

3.1

7.0

7.5

mmol/l

3.52

1016

8427

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

235

1483

1.62

10.68

3.5

2.4

0.7

0.6

1.51

223

1413

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

197

1188

1.69

10.68

3.0

2.9

0.3

u/ml

3.54

112

663

(3002385) Erythrocyte distribution width [Ratio]

2737

25215

1.27

10.64

29.6

17.7

14.0

13.8

13.43

2691

24571

(3040151) Glucose [Moles/volume] in Capillary blood

388

2.22

10.60

10.6

7.4

7.3

mmol/l

0.06

328

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

206

1270

1.66

10.28

1.9

2.5

3.6

3.8

g/l

1.58

145

930

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

206

1271

1.65

10.25

1.9

2.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

206

1271

1.65

10.25

1.9

2.5

7.4

g/l

0.11

151

961

(3017732) Neutrophils [#/volume] in Blood

288

1925

1.53

10.23

3.0

3.2

4.0

4.3

e9/l

1.19

207

1462

(3027273) Bicarbonate [Moles/volume] in Venous blood

247

1596

1.58

10.19

3.9

3.2

25.5

25.2

mmol/l

0.83

240

1539

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3046

28488

1.28

10.15

7.1

5.9

40.7

40.3

mmol/mol

1.24

2813

26055

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.53

10.03

3.7

2.4

114.3

111.3

umol/l

0.02

(3024891) Influenza virus A+B Ag [Presence] in Specimen

136

751

1.84

10.01

1.3

1.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

344

2397

1.48

10.00

4.3

3.7

1.0

0.6

1.30

554

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3435

32679

1.35

9.95

14.5

10.1

25.2

26.2

u/l

2.42

3336

31307

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

195

1197

1.66

9.91

1.8

2.5

10.4

g/l

0.01

160

1011

(3037756) Immunofixation for Serum or Plasma

132

727

1.84

9.81

1.5

1.6

—

(3037121) Protein [Mass/volume] in Urine

178

1076

1.68

9.60

3.2

3.0

0.2

0.3

g/l

0.46

447

(3020682) Albumin/Creatinine [Ratio] in Urine

1204

10195

1.26

9.57

4.1

3.9

9.9

9.3

mg/mmol

0.16

777

6516

(3027456) Digoxin [Moles/volume] in Serum or Plasma

137

773

1.80

9.42

3.3

3.0

0.8

nmol/l

0.10

104

579

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

134

752

1.81

9.38

1.8

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

415

2.10

9.37

1.7

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

139

790

1.79

9.34

3.7

2.7

1.7

1.6

mg/l

0.45

129

717

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

214

1366

1.60

9.31

2.0

1.9

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

357

2.18

9.29

1.4

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

167

1002

1.70

9.27

1.7

1.6

70.0

330.7

titre

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

107

561

1.93

9.26

1.9

1.5

—

(4015189)

3.82

9.21

2.1

2.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

144

831

1.76

9.19

2.3

2.5

3.7

g/l

0.23

133

786

(3028707) Methadone [Presence] in Urine by Screen method

301

2.28

9.17

2.1

2.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

373

2.14

9.11

1.2

1.1

5.8

1.9

u/ml

0.72

151

(3047181) Lactate [Moles/volume] in Blood

168

1018

1.68

9.00

5.1

5.6

1.5

1.3

mmol/l

1.27

150

903

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

349

2.17

8.98

1.4

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

349

2.17

8.98

1.4

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

2925

27359

1.25

8.94

25.7

15.8

38.3

39.5

6.60

1860

18513

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

6.69

8.89

1.0

1.1

0.0

0.7

u/ml

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

351

2.16

8.86

1.4

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

155

926

1.70

8.76

3.9

3.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

353

2.15

8.74

1.4

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

407

2.06

8.69

6.9

6.1

12.1

mg/l

0.01

370

(3024522) Salmonella sp identified in Specimen by Organism specific culture

354

2.14

8.68

1.4

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

189

1192

1.61

8.66

2.0

2.6

3.0

3.1

g/l

0.89

146

947

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

223

2.44

8.53

2.7

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

197

1260

1.59

8.52

1.8

—

(3052592) Norovirus Ag [Presence] in Stool

4.05

8.51

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

128

731

1.78

8.49

1.8

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

5.17

8.40

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

131

763

1.74

8.14

1.8

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

141

2.78

8.05

1.7

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

142

2.76

7.95

1.7

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

101

548

1.86

7.94

1.7

2.1

—

(3020891) Body temperature

202

1322

1.56

7.94

6.2

4.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

528

1.88

7.88

1.7

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

238

1626

1.49

7.67

2.8

3.4

4.3

4.4

pmol/l

1.44

209

1427

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

286

2.19

7.64

2.4

2.8

—

(3022621) pH of Urine by Test strip

291

2069

1.44

7.64

4.4

3.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

346

2.07

7.61

1.4

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

456

1.93

7.61

1.3

1.2

278.8

259.6

u/ml

0.27

274

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

367

2.03

7.57

2.0

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

102

3.05

7.57

24.6

24.2

116.0

108.1

ug/l

0.24

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

113

645

1.77

7.55

1.4

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

188

1225

1.56

7.55

1.2

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.49

7.53

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

176

2.52

7.48

1.4

1.3

2.5

1.0

u/ml

0.46

(3016879) Cocaine [Presence] in Urine

114

655

1.76

7.46

1.9

2.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

376

2.01

7.45

1.3

1.2

0.1

0.3

nmol/l

1.47

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

411

1.97

7.43

1.1

—

(4035726)

366

2726

1.38

7.35

1.4

1.3

—

(3011288) Drugs identified in Urine by Screen method

476

1.89

7.34

2.1

3.0

—

(3004451) EKG impression Narrative

172

2.52

7.32

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

263

1850

1.45

7.31

1.5

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

484

1.88

7.30

1.3

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

451

1.90

7.19

1.6

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

327

2.07

7.17

1.1

6.2

5.3

u/ml

0.12

164

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

169

1088

1.58

7.16

2.6

3.4

27.7

50.5

mg/l

2.46

132

888

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

131

792

1.68

7.15

2.4

2.3

102.6

93.5

ug/min

0.08

472

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

295

2.12

7.10

1.2

1.1

6.2

2.2

u/ml

0.43

125

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

390

1.97

7.09

1.2

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

131

794

1.67

7.08

1.7

1.3

38.9

14.7

iu/ml

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

169

1091

1.57

7.08

2.6

3.4

54.3

59.4

mg/l

0.25

131

889

(3017569) Oxygen content in Arterial blood

169

2.50

7.07

2.5

2.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

533

1.82

7.06

3.4

3.3

1.8

1.4

0.38

405

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

490

1.86

7.04

1.5

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

165

1061

1.58

7.04

2.6

3.4

6.9

3.0

ratio

—

(3043409) Potassium [Moles/volume] in Arterial blood

161

1031

1.58

6.99

5.8

3.7

3.9

mmol/l

0.18

152

958

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.39

6.96

1.9

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

123

737

1.69

6.95

1.9

12.3

mg/l

0.02

112

675

(40760888) Immunoglobulin light chains.free panel - Serum

131

801

1.66

6.86

2.7

3.6

—

(3006270) Folate [Moles/volume] in Blood

247

2.20

6.83

1.2

1.1

306.0

363.7

nmol/l

1.11

202

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.26

6.82

2.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

104

2.90

6.73

1.6

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

109

638

1.73

6.72

1.2

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

275

2.12

6.72

1.3

1.2

146.6

59.6

u/l

0.56

191

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

514

1.81

6.65

1.6

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

303

2.06

6.64

1.1

1.2

1.9

u/ml

0.39

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3141

29906

1.23

6.62

5.4

4.6

6.0

mmol/l

0.25

2859

26865

(3008401) Mugwort IgE Ab [Units/volume] in Serum

317

2.04

6.62

1.1

0.6

1.3

u/ml

0.73

134

(3017446) Testosterone [Moles/volume] in Serum or Plasma

324

2409

1.37

6.59

2.5

2.1

12.7

12.4

nmol/l

0.29

277

2094

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

163

2.47

6.58

1.4

1.6

3.2

3.5

u/field

0.07

115

(3008757) Leukocyte morphology finding [Identifier] in Blood

346

1.98

6.53

3.3

3.7

—

(3016750) Collection duration of Urine

176

2.40

6.51

2.6

2.0

518.7

489.4

min

1.61

122

(3024928) Oxygen saturation in Venous blood

114

682

1.69

6.51

3.7

2.6

—

(3027944) Amphetamines [Presence] in Urine

116

698

1.68

6.48

1.8

1.9

—

(3002256) Pathology report gross observation

516

4116

1.29

6.46

1.4

1.3

—

(40757373) Influenza virus identified in Isolate

3.40

6.41

2.0

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

335

1.99

6.39

1.1

—

(3012441) Differential panel - Pleural fluid

377

1.93

6.38

1.8

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

421

1.87

6.31

1.6

1.4

—

(4198724)

3.10

6.30

1.5

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

116

704

1.67

6.29

1.9

2.0

—

(3028300) Cannabinoids [Presence] in Urine

117

712

1.66

6.28

1.9

2.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.35

6.26

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

101

591

1.73

6.26

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

137

868

1.60

6.26

5.1

4.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

451

1.83

6.26

1.9

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.01

6.22

2.5

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

318

2.00

6.21

1.3

1.5

—

(3027008) Opiates [Presence] in Urine

116

708

1.66

6.16

1.8

2.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

476

1.80

6.13

1.6

1.3

—

(3042733) HLA Ab [Presence] in Serum

3.30

6.13

5.4

5.3

—

(3041354) Potassium [Moles/volume] in Venous blood

411

1.87

6.12

2.9

2.3

4.1

mmol/l

0.31

404

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

165

1098

1.52

6.09

2.7

3.3

2721.7

4621.3

u/ml

0.21

134

943

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

134

851

1.59

6.07

2.3

88.8

90.2

0.27

125

807

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.30

6.02

2.1

1.3

—

(3000330) Specific gravity of Urine by Test strip

231

1649

1.42

5.98

4.3

3.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.85

5.93

1.9

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

578

1.71

5.93

4.3

1.6

0.9

0.8

nmol/l

0.39

482

(3033705) Calcium.ionized [Moles/volume] in Venous blood

402

1.86

5.90

2.9

2.4

—

(3008295) Osmolality of Serum or Plasma

297

2.00

5.88

1.6

1.3

281.1

278.3

mosm/kgh2o

0.23

219

(3045424) Erythrocytes [Presence] in Urine

506

1.76

5.83

1.9

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

462

1.79

5.82

1.6

1.4

84.8

117.3

u/ml

1.45

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

131

2.53

5.77

1.1

1.2

117.1

97.5

u/l

0.18

(3047007) Chlamydophila sp Ab [Presence] in Serum

327

1.94

5.76

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

193

2.24

5.75

1.2

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.91

5.71

4.5

4.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

132

2.51

5.68

1.1

1.2

65.7

37.8

u/l

0.23

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

107

658

1.64

5.56

2.6

3.4

117.4

959.7

u/ml

1.30

610

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

196

2.21

5.55

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

347

1.89

5.49

1.4

2.1

—

(3008898) HLA-B27 [Presence]

124

794

1.58

5.47

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

217

2.13

5.47

1.7

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

160

2.32

5.41

1.2

1.1

—

(3040893) Potassium [Moles/volume] in Capillary blood

16.03

5.41

2.1

2.6

4.0

4.7

mmol/l

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

112

2.60

5.37

3.7

2.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

193

2.19

5.33

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

193

2.19

5.33

1.2

1.1

—

(3021788) Differential panel - Synovial fluid

535

1.70

5.33

1.8

1.5

—

(3051593) INR in Capillary blood by Coagulation assay

174

2.25

5.31

6.2

15.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

220

2.10

5.29

1.6

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

544

1.69

5.28

1.2

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

122

785

1.57

5.28

2.5

200.4

196.8

0.17

112

751

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

598

1.65

5.26

1.4

1.5

22224.5

1394.5

e6/l

0.46

490

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

598

1.65

5.26

1.3

1.4

61.2

28.0

e6/l

0.37

470

(3023430) Cat dander IgE Ab [Units/volume] in Serum

234

2.06

5.25

1.1

2.0

2.9

u/ml

0.41

(4306422)

374

1.83

5.25

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

150

2.34

5.23

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

150

2.34

5.23

1.1

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

169

2.26

5.22

1.6

11.7

6.8

u/l

0.73

(3018572) Chloride [Moles/volume] in Blood

114

724

1.59

5.22

5.7

6.4

104.2

105.1

mmol/l

0.90

104

644

(3039000) Anion gap in Blood

114

724

1.59

5.22

5.7

6.4

11.3

mmol/l

0.02

104

644

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

159

1087

1.48

5.21

2.3

2.6

1.2

g/l

0.04

137

929

(21494434) Karyotype in Bone marrow

276

1.97

5.20

1.2

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.34

5.15

1.2

1.1

0.8

0.6

umol/24h

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

196

2.15

5.15

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

196

2.15

5.15

1.2

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

100

618

1.63

5.12

1.9

206.7

207.8

pmol/l

0.04

585

(3024932) HLA-DR beta [Type]

3.01

5.09

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

415

1.77

5.07

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

364

1.83

5.07

1.6

1.5

58.8

62.0

0.24

228

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3007

28730

1.18

5.05

4.4

3.9

1.3

mmol/l

1.94

2719

25860

(3036489) Thrombin time

156

1070

1.48

5.04

2.2

2.1

21.7

21.6

0.07

134

958

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

308

1.90

5.01

1.6

1.5

22.4

27.5

0.66

196

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

545

1.67

5.00

2.2

2.1

9769.2

3173.4

u/l

0.37

213

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

179

2.19

4.99

1.4

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.87

4.91

1.3

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

262

1.96

4.86

1.1

1.0

4.3

2.8

u/ml

0.30

(3024471) HLA-A [Type]

2.93

4.86

1.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

326

1.85

4.84

2.8

3.2

60.0

58.7

0.16

203

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

108

691

1.58

4.82

1.3

487.6

557.2

mg/l

0.78

100

648

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.29

4.82

1.4

1.5

41.3

37.5

umol/l

0.20

(3049717) Cytology report of Urine Cyto stain

201

1459

1.40

4.79

2.7

2.8

—

(3007461) Platelets [#/volume] in Blood

3505

34014

1.24

4.76

36.3

21.3

245.3

244.3

e9/l

0.37

3428

32976

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

131

878

1.51

4.75

1.9

2.5

0.0

g/l

0.00

121

816

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

125

830

1.52

4.74

1.6

0.0

5.4

iu/ml

0.90

185

(3044941) Cell count panel - Synovial fluid

492

1.68

4.73

1.7

1.4

—

(3024731) MCV [Entitic volume]

3506

34029

1.24

4.73

36.1

21.3

91.4

0.04

3460

33404

(3035941) MCH [Entitic mass]

3506

34030

1.24

4.72

36.1

21.2

30.3

30.4

2.88

3460

33405

(3026361) Erythrocytes [#/volume] in Blood

3506

34032

1.23

4.70

36.2

21.3

4.4

4.5

e12/l

19.50

3416

32877

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

132

891

1.50

4.64

1.9

2.5

0.0

g/l

0.50

122

818

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

146

1006

1.47

4.63

1.8

2.4

37.5

37.3

g/l

0.21

128

866

(3010813) Leukocytes [#/volume] in Blood

3506

34042

1.23

4.63

36.3

21.4

7.0

6.8

e9/l

2.71

3420

32865

(3000963) Hemoglobin [Mass/volume] in Blood

3506

34043

1.23

4.62

36.5

21.5

131.5

135.1

g/l

34.44

3459

33420

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

318

1.84

4.57

1.4

1.2

—

nmol/l

—

(3004775) Volume in Urine collected for unspecified duration

255

1.93

4.53

2.9

2.2

750.9

627.5

1.20

153

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

326

2569

1.29

4.51

3.2

2.6

61.3

64.1

ml/min/173m2

0.71

139

1053

(3004616) Nuclear Ab [Presence] in Serum

306

1.84

4.47

1.4

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

117

2.40

4.46

1.4

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

117

2.40

4.46

1.4

1.6

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

2.59

4.46

1.0

0.2

7.3

u/ml

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

114

753

1.53

4.45

1.4

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

105

2.49

4.45

1.0

0.6

0.5

u/ml

0.20

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

138

951

1.47

4.40

2.0

2.5

0.0

0.1

g/l

0.47

128

874

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

156

2.19

4.39

1.9

2.3

541.3

505.2

e6/l

0.16

132

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

397

1.72

4.36

1.3

1.2

5.3

4.6

u/ml

0.12

165

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.66

4.31

1.1

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.66

4.31

1.3

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

119

2.36

4.31

1.4

1.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

615

1.57

4.30

1.3

3.8

3.9

mmol/l

0.11

571

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

218

1.98

4.30

1.1

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

384

1.73

4.29

2.2

2.1

37.3

25.3

mg/l

0.66

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

326

1.79

4.25

1.1

1.5

g/l

0.32

289

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

185

2.06

4.24

1.8

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

185

2.06

4.24

1.8

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

403

1.70

4.15

1.9

1.4

22840.4

77602.5

e6/l

1.72

248

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

147

2.19

4.14

2.0

2.4

0.3

0.2

e9/l

0.73

131

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

128

2.27

4.12

1.2

1.1

1.0

1.1

ratio

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

489

4085

1.22

4.10

9.9

7.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

279

1.84

4.09

1.7

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

188

2.03

4.07

3.6

4.0

—

(3045414) Leukocytes [Presence] in Urine

185

1365

1.37

4.05

2.3

1.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

454

1.64

3.98

2.0

1.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.67

3.98

1.2

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

6.44

3.98

5.2

1.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

110

741

1.50

3.96

1.7

1.6

15852.1

14976.3

e6/l

0.08

531

(40768446) Kidney Pathology biopsy report

2.48

3.95

2.1

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

364

1.71

3.94

1.1

121.4

114.2

0.70

326

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

191

2.00

3.92

2.4

1.8

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

144

2.16

3.92

1.1

11.8

12.0

iu/ml

—

(3003434) Protein [Mass/volume] in Pleural fluid

503

1.60

3.91

1.9

1.4

31.6

31.8

g/l

0.05

457

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

106

2.37

3.89

3.1

2.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

291

1.80

3.89

1.6

1.5

—

(3044927) Protein electrophoresis panel - Urine

328

1.75

3.89

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.57

3.88

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.57

3.88

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

2.57

3.88

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.57

3.88

1.1

1.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

158

2.10

3.87

1.3

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

158

2.10

3.87

1.3

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

158

2.10

3.87

1.3

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

158

2.10

3.87

1.3

1.5

—

(40768443) Skin Pathology biopsy report

175

1290

1.37

3.87

1.3

1.2

—

(4133840)

2.78

3.85

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

186

2.00

3.82

1.0

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

102

2.36

3.73

1.0

0.3

0.4

u/ml

0.88

(3037556) Urate [Mass/volume] in Serum or Plasma

2.45

3.71

2.0

1.4

—

(3005570) Glucose [Moles/volume] in Urine

318

1.74

3.71

2.1

1.9

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.01

3.68

1.3

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

410

1.64

3.67

1.3

1.2

4.2

4.8

u/ml

0.07

131

(3042111) Morphology [Interpretation] in Bone marrow Narrative

576

1.54

3.65

1.5

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.86

3.62

2.2

1.0

—

(40768806) Pleura Pathology biopsy report

381

1.66

3.62

1.9

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

642

1.51

3.61

1.5

1.8

121.9

4.6

iu/l

0.48

210

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

156

2.06

3.60

1.2

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

240

1.84

3.60

2.1

2.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

292

1.76

3.57

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

130

2.16

3.57

1.3

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.57

3.54

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.45

3.54

1.8

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

271

1.78

3.52

1.5

2.0

2.4

1.9

u/field

0.28

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.62

3.46

1.1

66.0

85.8

—

(3033799) Differential panel - Peritoneal fluid

2.48

3.45

3.9

1.9

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.54

3.45

1.8

1.5

11.0

8.5

ug/l

0.70

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

311

1.71

3.42

1.6

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

2.99

3.41

1.4

2.2

105.0

201.6

e6/l

—

(3006576) Bicarbonate [Moles/volume] in Blood

2.35

3.40

6.0

7.1

25.7

25.0

mmol/l

0.36

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

441

3717

1.21

3.39

4.9

4.5

32.9

32.6

0.15

295

2399

(3011412) CD3 cells [#/volume] in Blood

238

1.82

3.38

2.0

2.4

1.2

1.1

e9/l

0.20

143

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.58

3.37

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

231

1.83

3.37

1.1

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

5.01

3.36

1.1

1.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

429

1.59

3.33

3.2

4.8

335.7

355.8

umol/l

0.53

361

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3083

29804

1.15

3.32

4.9

4.4

1.4

mmol/l

1.06

2803

27044

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

141

2.06

3.31

1.2

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

141

2.06

3.31

1.2

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

8.58

3.26

1.5

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.78

3.25

1.2

1.6

146.7

164.7

ng/l

0.10

(3017704) Immunofixation for Urine

191

1.89

3.23

1.6

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

386

1.62

3.22

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1379

12721

1.13

3.21

5.3

5.1

2.7

4.1

ug/l

2.00

1245

11317

(4268621)

272

1.74

3.20

2.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

120

860

1.41

3.20

1.5

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

442

1.57

3.19

1.9

1.4

5931.0

1651.0

e6/l

0.85

324

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.37

3.18

8.6

3.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

251

2011

1.26

3.12

2.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

533

1.51

3.11

1.3

1.2

46.1

36.5

u/l

0.35

458

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

203

1585

1.30

3.10

1.2

76.0

148.0

iu/ml

2.35

569

(3006462) Nitrate [Presence] in Urine

145

2.01

3.09

4.3

3.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

897

8069

1.14

3.08

1.7

1.6

1.4

mmol/l

0.26

752

6705

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

153

1.97

3.04

2.5

2.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

182

1.88

3.00

1.6

1.8

6.9

6.5

umol/l

0.06

122

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

175

1.89

2.99

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

175

1.89

2.99

1.5

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

482

1.52

2.97

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

256

1.73

2.97

1.0

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

279

1.69

2.95

1.3

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

279

1.69

2.95

1.3

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

279

1.69

2.95

1.3

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.47

2.95

1.1

1.4

76.0

83.0

—

(44790048)

333

1.63

2.94

2.0

1.4

—

(44790047)

333

1.63

2.94

2.0

1.4

—

(44806118)

333

1.63

2.94

2.0

1.4

—

(44790049)

333

1.63

2.94

2.0

1.4

—

(3014271) Vancomycin [Susceptibility]

198

1.83

2.93

3.3

3.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

128

2.04

2.90

1.0

7.0

65.3

61.3

mg/l

0.12

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

156

1.93

2.89

1.5

1.1

18.6

16.2

u/l

0.23

129

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

199

1.82

2.88

1.2

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

289

1.67

2.87

1.1

—

(4211845)

157

1.92

2.84

4.2

3.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3100

30072

1.13

2.84

5.0

4.4

4.5

4.6

mmol/l

3.38

2840

27483

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

362

1.58

2.78

1.4

1.3

213.3

269.3

pmol/l

1.48

274

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

370

1.58

2.77

2.2

1.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3168

30788

1.14

2.77

5.5

5.0

2.6

2.7

mmol/l

6.17

2897

27977

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

166

1.87

2.75

2.4

1.6

4.8

6.8

u/l

1.68

141

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

203

1.78

2.72

1.2

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

218

1.75

2.71

1.1

1.0

0.1

0.4

u/ml

0.73

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.60

2.70

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

227

1836

1.25

2.64

2.0

1.9

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

206

1.75

2.61

1.2

1.3

9.9

11.6

mmol/l

0.51

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

236

1.70

2.60

1.0

1.1

—

(3019977) pH of Arterial blood

184

1.80

2.60

4.2

2.5

7.4

0.32

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

163

1.85

2.57

1.5

1.1

60.9

80.8

u/l

1.19

138

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.13

2.54

1.5

1.3

86.0

513.0

ug/l

—

(3016018) Differential panel - Cerebral spinal fluid

269

1.64

2.52

1.2

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

108

2.04

2.51

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

143

1.89

2.50

1.2

1.3

5.8

6.0

mmol/l

1.01

137

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.82

2.47

1.6

1.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

180

1.78

2.47

1.7

2.3

18.6

12.8

0.97

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

225

1.70

2.46

1.6

1.5

—

(3011985) Renin [Units/volume] in Plasma

382

1.53

2.45

1.4

1.3

35.2

60.8

mu/l

0.78

331

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.46

2.44

1.6

1.4

18.2

29.2

g/l

—

(3045142) Bone marrow Pathology biopsy report

351

1.55

2.42

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.09

2.42

1.9

2.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

168

2110

0.79

2.41

1.8

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

6.25

2.37

6.0

6.5

334.6

388.1

umol/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

102

753

1.36

2.36

5.0

3.5

34.6

29.6

mg/l

0.64

487

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

213

1.70

2.35

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

351

3006

1.18

2.33

1.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

184

1.74

2.31

2.3

2.2

866.2

647.4

e6/l

0.54

(3006653) Thiamine [Moles/volume] in Blood

133

1.88

2.30

1.2

1.1

124.8

137.5

nmol/l

0.92

133

(3001893) Eosinophils/100 leukocytes in Pleural fluid

126

1.91

2.30

1.3

1.4

1.0

2.7

1.84

107

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

177

1.76

2.29

1.7

2.3

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

192

1.72

2.29

1.2

1.1

7.8

4.3

u/ml

—

(3045788) Cell count panel - Pleural fluid

356

1.52

2.29

2.0

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

698

1.37

2.28

1.8

1.7

296.4

307.9

mu/l

0.10

641

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

285

1.59

2.27

1.2

1.1

—

3.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

2.46

2.27

1.8

3.2

43.2

46.2

u/l

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.78

2.20

1.0

1.2

—

(4281824)

280

1.58

2.19

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

172

2123

0.80

2.16

1.3

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

144

1.81

2.14

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

189

1.70

2.13

3.7

2.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

109

1.93

2.10

1.2

1.3

23.1

24.4

0.06

102

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

261

1.58

2.05

1.2

1.1

—

(3048879) Bone marrow aspiration report

2.03

2.05

2.4

1.5

—

(3035880) pH of Pleural fluid

207

1.65

2.03

1.4

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

207

1.65

2.03

1.3

1.2

58.6

93.4

titre

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

129

1012

1.28

2.01

2.0

1.9

—

(4027681)

140

1.79

2.00

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.82

2.00

1.1

1.2

1.3

1.7

umol/24h

—

(3003338) MCHC [Mass/volume]

2635

25520

1.09

1.98

31.4

18.9

331.1

332.3

g/l

8.06

2602

25271

(3051651) Icteric interference index of Serum or Plasma

186

1.67

1.97

4.7

3.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

108

1391

0.77

1.96

1.5

1.4

—

(3023410) Appearance of Cerebral spinal fluid

249

1.57

1.95

1.4

1.6

—

(3034426) Prothrombin time (PT)

1.98

1.94

1.2

1.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

1.94

1.2

1.0

97.3

89.7

0.69

(3013293) Extractable nuclear Ab [Presence] in Serum

2.57

1.92

2.0

1.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.57

1.92

1.6

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

274

1.54

1.91

1.5

1.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.24

1.90

2.4

1.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

165

1.70

1.90

1.3

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.96

1.89

1.2

40.9

38.3

g/l

—

(3020393) Adenovirus Ag [Presence] in Stool

3.18

1.88

1.4

1.0

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

151

1.73

1.86

1.3

1.4

69.1

64.3

0.25

125

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.86

1.86

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

104

803

1.30

1.85

1.8

—

(3003694) ABO and Rh group [Type] in Blood

872

8058

1.10

1.85

1.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

129

1.79

1.85

1.0

1.4

—

63.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

182

1.65

1.84

1.0

1.1

241.8

303.7

mg/l

1.92

154

(40768441) Liver Pathology biopsy report

190

1.64

1.83

1.5

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

152

1.71

1.83

1.2

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

640

1.33

1.81

1.5

1.4

11.0

9.8

u/l

0.29

520

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

168

1.67

1.80

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.76

1.79

1.0

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

279

1.51

1.78

1.7

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.17

1.77

4.6

2.2

—

(3044007) Cell count panel - Peritoneal fluid

2.03

1.74

2.3

1.9

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

117

1.80

1.74

1.6

2.4

7.2

nmol/l

0.70

100

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1093

10241

1.09

1.72

4.5

4.4

21.5

22.1

0.64

544

5216

(3010144) Erythrocytes [#/volume] in Synovial fluid

298

1.48

1.72

1.3

168619.2

65455.8

e6/l

0.44

212

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

290

1.49

1.71

1.1

—

2.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

234

1.54

1.70

1.8

1.7

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

187

1.61

1.68

1.1

30.7

46.8

mg/l

3.81

153

(3025549) Creatine [Moles/time] in 24 hour Urine

2.80

1.65

1.7

1.5

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

2.03

1.64

1.7

3.5

6.0

7.3

mg/l

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

3.57

1.61

2.4

1.1

4.6

0.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.33

1.60

1.1

1.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.50

1.59

2.3

2.5

0.4

0.5

u/field

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.50

1.59

1.0

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.07

1.59

4.6

8.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.95

1.59

2.7

2.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

229

1965

1.18

1.57

1.4

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

129

1.71

1.56

1.8

2.0

57.8

52.4

umol/l

0.28

106

(3023487) Leukocytes [#/volume] in Peritoneal fluid

1.85

1.55

2.2

195.7

9151.5

e6/l

0.57

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.28

1.53

11.6

4.0

6.0

mmol/l

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.59

1.51

1.1

1.4

—

mmol/l

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

138

1.67

1.51

1.0

1.1

1.0

1.1

u/l

0.75

(3028433) Virus identified in Specimen by Culture

1.81

1.47

1.1

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

326

1.42

1.46

4.2

3.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.50

1.45

1.1

1.2

7.1

10.3

u/l

—

(3046861) Legionella sp Ag [Presence] in Urine

3.13

1.44

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.04

1.43

1.5

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

278

1.44

1.42

1.4

1.5

0.2

0.3

nmol/l

0.55

209

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

1.85

1.40

2.3

1.9

351.9

7248.4

e6/l

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

364

1.38

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.94

1.36

2.0

1.1

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

2.94

1.36

2.4

1.2

15.8

7.2

—

(3009871) Measles virus Ab [Titer] in Serum

1.91

1.33

1.5

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

192

1.51

1.31

2.0

1.9

—

(3045716) Anion gap in Serum or Plasma

168

1.55

1.31

2.5

2.3

10.9

9.5

mmol/l

0.44

134

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.50

1.30

2.3

2.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

217

1.48

1.30

1.1

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.10

1.30

1.3

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

352

1.37

1.29

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.78

1.28

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.09

1.27

4.5

8.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.00

1.27

1.3

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

741

1.25

1.26

1.4

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

354

1.36

1.25

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.40

1.24

1.2

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.22

1.24

2.5

2.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.91

1.22

1.3

1.6

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

2.63

1.21

2.2

1.2

54.8

48.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.16

1.21

2.4

2.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

124

1.62

1.20

2.3

1.3

21.8

27.2

umol/l

0.39

117

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

621

1.26

1.19

1.4

1.3

181.6

210.7

miu/ml

0.33

262

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.83

1.19

5.1

8.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.11

1.18

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.70

1.17

1.1

1228.4

1568.5

miu/ml

0.65

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.93

1.16

1.5

1.2

243.0

278.9

pmol/l

—

(4146454)

333

1.36

1.16

2.1

2.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.00

1.16

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.50

1.15

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

174

1.50

1.15

2.6

2.2

13.7

14.9

umol/l

—

(40768793) Breast Pathology biopsy report

608

1.25

1.13

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.00

1.12

1.1

1.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.19

1.08

1.1

1.3

20.6

20.5

u/l

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

348

1.33

1.05

1.4

1.3

7.2

7.7

mmol/l

0.48

254

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.06

1.02

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

130

1.54

1.02

1.1

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

172

1.46

0.99

6.9

6.6

—

(3047189) Immunofixation for 24 hour Urine

164

1.47

0.99

1.2

1.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.95

0.97

1.3

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.95

0.97

1.0

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.95

0.97

1.1

1.9

14.8

18.7

umol/l

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.85

0.96

1.1

1.2

—

109.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

207

1.40

0.96

1.3

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

443

1.27

0.95

1.1

17.9

84.7

iu/ml

1.27

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

107

907

1.18

0.94

1.6

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

379

3490

1.09

0.93

1.5

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.82

0.92

1.1

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.00

0.87

1.3

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

128

1.49

0.85

1.1

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

100

852

1.18

0.85

1.5

1.3

31.4

30.5

iu/l

0.08

724

(44813793)

162

1.42

0.84

1.2

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

262

0.69

0.83

1.3

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

130

1.46

0.80

1.4

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

276

1.31

0.80

1.4

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.67

0.78

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

256

0.70

0.75

1.3

1.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.08

0.74

1.2

1.3

—

(3005033) Fetal Nuchal fold Thickness US

255

0.70

0.74

1.3

1.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.00

0.72

1.6

2.0

—

(3025315) Body weight

2.00

0.72

4.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.61

0.72

2.4

3.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

124

1093

1.14

0.71

1.8

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

168

1.37

0.71

4.1

3.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

151

1.39

0.71

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.92

0.70

1.2

—

(3026480) Teichoate Ab [Titer] in Serum

1.92

0.70

1.2

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

1.51

0.69

6.0

5.6

62.9

71.8

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.85

0.68

2.4

4.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.49

0.66

1.9

2.3

—

(44806071)

1.79

0.66

1.2

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.79

0.66

2.0

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.59

0.65

1.0

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

163

1.35

0.64

1.9

2.7

41.2

36.9

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.55

0.62

1.5

0.5

ug/l

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.59

0.61

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.57

0.60

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

105

1.43

0.60

5.2

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

105

1.43

0.60

5.3

2.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.59

0.0

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

157

1.34

0.59

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

210

1.29

0.58

1.0

247.2

304.0

ng/l

0.67

131

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

210

1.29

0.58

1.0

31.8

43.0

ng/l

1.00

129

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.48

0.57

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

211

1.28

0.57

1.0

783.7

690.7

ng/l

0.58

124

(3029075) Extractable nuclear Ab panel - Serum

1.51

0.56

1.0

—

(3002619) Bacteria identified in Specimen by Culture

1.46

0.56

1.3

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

194

1.29

0.55

2.0

2.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.58

0.54

2.5

1.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

241

1.25

0.52

5.4

5.3

33.7

57.0

u/ml

0.38

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

337

0.80

0.51

1.4

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

161

1.31

0.51

1.2

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

296

1.22

0.51

2.6

3.1

22.7

33.1

mg/l

0.26

229

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

314

0.79

0.50

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

314

0.79

0.50

1.3

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

145

0.69

0.50

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.46

0.50

1.2

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

313

0.80

0.49

1.3

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

180

1.28

0.49

1.8

1.5

0.9

g/l

0.02

180

(1002224) Polysomnography panel

113

1023

1.11

0.47

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.41

0.46

1.4

28.8

20.3

0.40

(3014051) Protein [Presence] in Urine by Test strip

711

1.13

0.46

2.7

2.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

147

1.29

0.45

1.4

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.40

0.44

1.9

1.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

121

1.32

0.44

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.61

0.43

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.61

0.43

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.61

0.43

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.56

0.42

1.2

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.56

0.42

1.0

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

114

1.32

0.40

1.1

—

474.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

205

0.78

0.40

1.5

1.4

54.6

197.0

pmol/l

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

2.1

—

1.8

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.40

0.0

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

314

0.83

0.39

1.3

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.41

0.39

1.0

1.2

—

(4024509)

298

1.18

0.38

2.2

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

385

0.86

0.36

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

273

1.17

0.35

1.3

1.4

22.2

28.1

u/l

0.35

224

(3013166) Neutrophils/100 leukocytes in Synovial fluid

118

1.27

0.33

1.3

76.6

58.3

2.14

(3011648) Oxygen content in Venous blood

275

1.16

0.32

2.6

1.8

8.8

10.9

1.86

275

(3024263) Appearance of Synovial fluid

192

1.20

0.32

1.4

1.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

110

1.27

0.31

2.2

2.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.32

0.30

1.0

1.1

—

(3014891) Appearance of Pleural fluid

1.27

0.30

1.4

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.25

0.29

1.0

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

148

1.22

0.29

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.28

0.26

1.2

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

197

1.17

0.25

1.3

1.5

—

(3020650) Glucose [Presence] in Urine

1.17

0.24

2.2

1.4

—

(3016228) CD19 cells/100 cells in Blood

115

1.22

0.23

2.3

4.1

8.4

1.69

110

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

453

0.90

0.23

4.1

3.8

47.2

33.2

u/ml

0.37

438

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

106

1.23

0.23

1.3

1.1

—

(40758292) HTLV I+II Ab panel - Serum

1.28

0.23

1.0

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.25

0.22

1.6

1.9

—

(3022689) Creatine [Moles/volume] in Urine

1.25

0.22

1.4

1.5

—

(40768795) Lymph node Pathology biopsy report

295

1.12

0.22

1.1

1.2

—

(3036603) Volume of Urine

210

1.14

0.21

1.4

1.5

2159.6

1790.3

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

262

0.88

0.21

1.5

1.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.16

0.21

1.2

1.0

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.20

0.0

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

111

0.81

0.20

1.8

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.23

0.18

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.23

0.18

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

121

0.83

0.18

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.15

0.17

1.0

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

1.11

0.17

1.1

1.8

—

(3019832) Treponema pallidum Ab [Presence] in Serum

174

1680

1.04

0.16

1.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.18

0.16

1.0

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

120

1.17

0.16

1.2

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.10

0.15

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.10

0.15

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

604

0.94

0.14

1.6

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

696

1.05

0.13

1.6

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

744

7350

1.01

0.13

3.1

0.8

ug/l

0.13

549

5019

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

240

0.92

0.11

1.8

1.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

494

1.05

0.11

1.1

—

(44806420)

105

1.14

0.11

2.3

2.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

270

1.07

0.10

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.09

0.09

1.0

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

623

0.96

0.08

1.4

1.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.79

0.08

2.8

3.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.77

0.08

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

215

1.07

0.07

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.05

0.07

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

305

0.95

0.06

1.1

—

(1761868) Lipid panel - Serum or Plasma

1000

9951

1.01

0.05

3.4

3.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.10

0.04

1.1

—

(4034850)

101

1026

0.98

0.04

16.4

10.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.09

0.03

1.1

—

(3000012) Reticulocyte production index

197

0.96

0.01

1.4

—

(40768800) Prostate Pathology biopsy report

813

1.00

0.00

1.2

—

(3025577) Chromium [Mass/volume] in Blood

211

1.00

0.00

2.0

2.1

1.8

2.1

ug/l

0.16

177

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

581

1.00

0.00

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

885

0.99

0.00

1.7

6.1

3.2

mg/l

0.88

626

(3015183) Erythrocyte sedimentation rate

124

0.97

0.00

1.1

1.2

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.5

—

3421.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.4

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

2.9

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.8

—

2.3

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3024869) Neuronal Ab [Presence] in Serum

0.97

0.00

1.2

1.1

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.0

1.0

—

0.9

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_OTHDISOES and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_OTHDISOES	1.631 [1.47, 1.81]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.189

During the follow-up period (1.1.1998 — 31.12.2019), 2146 out of 7088 females with K11_OTHDISOES died.

Males

Parameter	HR [95% CI]	p-value
K11_OTHDISOES	1.977 [1.78, 2.19]	< 0.001
Birth year	0.982 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 3602 out of 9535 males with K11_OTHDISOES died.

Mortality risk

Mortality risk for people of age

years, who have K11_OTHDISOES.

N-year risk	Females	Males
1	0.118%	0.288%
5	0.876%	2.143%
10	2.228%	5.142%
15	4.277%	8.977%
20	7.988%	14.684%

Relationships between endpoints

↥

Index endpoint: K11_OTHDISOES – Other diseases of oesophagus

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other diseases of oesophagus

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints